« May 2005 | Main | July 2005 »

June 30, 2021

Mahaveer Mehta, Dubai based Dermatologist, Introduces Titan Facelift and Body lift; Noninvasive, Non-Surgical Skin Tightening Solution; Avoids Invasive Cosmetic Procedures

The Titan Procedure is a safe, non-surgical process that uses an infrared light source to tighten skin and reverse the signs of aging. The Titan heats the dermis to cause collagen contraction while preserving the epidermis through continuous cooling. In addition, Titan can stimulate long-term collagen rebuilding that leaves patients with younger looking skin. Excellent long term results are obtained for those who wants to tighten their skin without side effects and do not wish to go under the surgical knife.

(PRWEB) June 30, 2021 -- Dr. Mahaveer Mehta Medical Center, Dubai, United Arab Emirates, is one of the first in this part of world to have the latest safe light based solution for aging skin. The Titan Procedure treats lax and redundant skin throughout the body including the abdomen, thighs and underarms and is also used to tone, lift and tighten skin on the face, neck and other parts of body.

The Titan Procedure is a safe, comfortable, non-surgical treats lax and redundant skin throughout the body -- can stimulate long-term collagen rebuilding. Although non-ablative radiofrequency can produce skin tightening, significant pain from its application limits the patient population of possible candidates to those with sufficiently high pain tolerance and those willing to undergo significant pain during the procedure. Topical anesthetics are only modestly helpful in lessening this pain. Injectable anesthetics are not recommended due to the possibility of altering the local impedance of tissues, causing an unwanted burn. Producing painless skin tightening via non-ablative radiofrequency is not yet possible unless the patient is deeply sedated or receives systemic anesthesia.

A new non-ablative medical device: Titan (Cutera, Inc. Brisbane, CA) has been successful in producing skin contraction leading to lifting of eyebrows and/or improvement of lower face and neck skin laxity. This device has also been used successfully in other body areas such as abdomen, arms and thighs. Immediate changes have been noticed in the vast majority of patients. There is hardly any pain , to the point of needing no anesthesia. Patient satisfaction has been remarkable. There is no down time and no incisions or scars either. Additionally, the patient will look much better and younger after the procedure. The results have a remarkable natural look which, plastic surgery rarely can match. The patient will look less tired , with a freshened look. The skin contraction achieved is in the order of 1 to 4 millimeters. It may not sound dramatic, but the changes induced by such contraction are perceptible and significant when it comes to eyebrow lifting or fading of the naso-labial fold. Follow-up visits show that the improvement has been maintained and even increased. In fact, the degree of improvement has not diminished during follow-up in any of our patients. Post operative patients can go back to their normal activities right away.

The new Titan system from Cutera has a similar thermal profile in ex-vivo skin specimens detected by thermal photography. It also has significant advantages over non-ablative radiofrequency called Thermage . For one thing it has a multi-second pulse which provides a gentle and sustained skin heating that clinically is much less painful and has similar if not better clinical results as compared to Thermage. The safety profile is very good with adequate physician training and the results are as satisfactory as can be expected with any modern technology in this field.

Titan in the news:
http://cutera.com/photos/articles
http://www.skinlaserdubai.com/TITAN/titan.html

Posted by Industrial-Manufacturing at 02:45 AM | Comments (0)

Innovation Drives European Transcatheter Embolization and Occlusion Market Growth

According to a report published by Millennium Research Group (MRG), the European market for transcatheter embolization and occlusion (TEO) devices, including embolization coils and particles, liquid embolics, coiling-assist devices, guidewires and catheters, and heart defect closure devices, generated over $125 million in 2004.

June 30, 2005—Europe’s aging population is increasingly susceptible to cancer and cardiovascular disease, generating a growing demand for effective medical treatments. Medical manufacturers have responded with the development of a range of new embolization and occlusion technologies to treat aneurysms, uterine fibroids, tumors, and a host of other conditions.

According to a report published by Millennium Research Group (MRG), the European market for transcatheter embolization and occlusion (TEO) devices, including embolization coils and particles, liquid embolics, coiling-assist devices, guidewires and catheters, and heart defect closure devices, generated over $125 million in 2004.

Despite the limitations imposed by physician referral patterns, minimal reimbursement, and the absence of long-term clinical data, the continuing adoption of innovative, premium-priced devices, such as endovascular cerebral aneurysm coils, microspheres, and heart defect closure devices, will support 10% annual TEO market growth through 2009.

MRG’s European Markets for Transcatheter Embolization and Occlusion Devices 2005 examines the innovations transforming interventional neuroradiology (INR), peripheral vascular (PV), and interventional cardiology (IC) procedures across Europe. The report identifies the technologies that will drive revenue growth over the next five years and the competitors poised to capitalize on these opportunities.

As the leader in multiple segments of the TEO market, Boston Scientific currently holds—and should maintain—a distinct competitive advantage in Europe. Thanks to the strong performance of its Amplatzer heart defect closure devices, AGA Medical trailed only Boston Scientific in total European TEO revenues in 2004. MRG’s new report also examines other key competitors in the TEO market, including Cordis, Micro Therapeutics, Inc., Terumo, Micrus Corporation, Cook, Microvention, Inc., Cardia, Inc., BioSphere Medical, NMT Medical, Balt, W.L. Gore, and ev3.

A leading source of competitive intelligence, MRG is now the largest provider of medical device market research in the world. Located in Toronto, Canada, MRG covers global markets and has pioneered reporting of numerous emerging products.

Contact Information:
Derrick Navarro
Millennium Research Group Inc.
(416) 364-7776 ext. 133
e-mail protected from spam bots
www.mrg.net

Posted by Industrial-Manufacturing at 02:44 AM | Comments (0)

June 29, 2021

Patient Communication Board Featured on Science Today Radio Talk Show, Reduces Patient Stress

Lance Patak, a critical care nurse at UCLA’s Cardiothoracic ICU and creator of the EZ Board patient communication board, was interviewed by Larissa Branin for the Science Today radio talk show. The interview discussed the features of the EZ Board and how it can reduce frustration levels during communication with intubated patients.

(PRWEB) June 29, 2021 -- Lance Patak, a critical care nurse at UCLA’s Cardiothoracic ICU and creator of the EZ Board patient communication board, was interviewed by Larissa Branin for the radio talk show, Science Today. The interview discussed the features of the EZ Board and how its communication system, which was developed by patients, can meet the communication needs of intubated patients with significantly reduced frustration levels.

There are two kinds of Intensive Care Unit patients, according to Lance Patak. “You have patients who anticipate being in the ICU after elective surgeries, and you also have trauma patients, who were driving down the road and suddenly wake up with alarms going off and a tube down their throat. [Both kinds of patients are unable to speak, and they have a lot of questions and concerns when they wake up.”

Patient communication is limited in these situations and can be very frustrating for the patients, their nurses, and the patients’ loved ones. Before the EZ Board patient communication board, patient communication was limited to how well a nurse could make out a patient’s gestures or words around a tube, or in some situations, using an alphabet chart. Unfortunately, the alphabet chart was also severely limited.

“The problem [with the alphabet chart is the patient starts to spell, but [the nurse doesn’t know when the word ends or a new one begins, or if they miss a letter, there’s so much effort in trying to find the letter and go around, it’s almost futile and exhausting for the patients.”

The EZ Board patient communication board was designed by patients who were or had been in this situation. It features:
- Large, easy-to-read text
- “I Am…” column to indicate state of being (I am short of breathe, I am thirsty, I am afraid, I am in pain, I am unsure of what is happening)
- “I Want…” column to indicate wants and needs (I want to be suctioned, I want my family, I want a blanket, I want the lights on or off)
- Pictures of the body which the patient can use to indicate needs in a certain area
- Color-coded pain intensity levels from 0-10 to describe listed discomforts (itching, stings, cramps, can’t move, is numb, burns, is tender)
- A time frame so the patient can indicate when he or she would like these needs met (immediately, later, as soon as possible)

“It also enables patients to thank their practitioner, something that many of the patients testing the patient communication board requested specifically,” added Patak.

The EZ Board patient communication board is very lightweight and very inexpensive. According to research done by Patak, patients do not want the patient communication board to be something that the nurses or the hospitals own; they want to own it themselves. Patak designed the patient communication board to be affordable and disposable for that reason.

The EZ Board patient communication board has been utilized successfully at several hospitals, including UCLA. Patient evaluations have shown that the patient communication board can significantly reduce frustration levels, provide a more efficient method of patient communication, and decrease the need for pain or anxiolytic medication.

Patak believes the EZ Board patient communication board has the potential to reduce the hours of both surgical- and emergent-intubation as well as hospital stay, but states those variables need to be tested by an experimental study. At this time, that research has not been done.

The EZ Board patient communication board is available with either Spanish or English text. For further information about the EZ Board or to order a patient communication board, visit www.Vidatak.com. Excerpts from the Science Today interview can be reviewed at www.ucop.edu/sciencetoday.

About Vidatak, LLC
Established in 1999, Vidatak Enterprises began distributing their patient communication boards to hospitals all over the country. By 2003, Vidatak had changed its name, ownership, and business models. Now, Vidatak, LLC continues to present their research findings and critical care patient communication aids at various conferences, seeking distributors in critical care, rehabilitation medicine, and speech pathology and therapy.

Posted by Industrial-Manufacturing at 01:35 AM | Comments (0)

DanceswithBulls.com 2005 Stock Pick of the Year - Cord Blood America Inc. (CBAI.OB) - A Cord Blood Stem Cell Banking Company

DanceswithBulls.com discusses it's 2005 Stock Pick of the Year - Cord Blood America, Inc. (CBAI.OB), a Stem-Cell company that continues to produce outstanding results!

(PRWEB) June 29, 2021 -- In recent months, there has been considerable excitement and discussion on Wall Street regarding Stem Cell companies and what many perceive to be the beginning of a Biomedical Revolution. While many of these companies emphasize that they have may not produce any significant revenue for years to come, investors continue accumulating shares and prices continue to achieve new 52 week trading highs. Some of these companies are as follows: StemCells Incorporated (STEM: NASD), Aastrom Biosciences (ASTM: NASD), ViaCell (VIAC: NASD), Geron (GERN: NASD) and CyCro Cell Inc. (CCEL: OTCBB).

Today we discuss a Stem Cell company that has only recently started trading on the Bulletin Board Exchange and that is relatively undiscovered by the masses. Not only has it yet to be discovered, it also is a Stem Cell company that actually earns revenue and has in fact has increased for 9 consecutive quarters!

After reviewing hundreds of Bulletin Board stocks in search of a company that had the potential of providing our members with considerable long-term gains from current price levels, it quickly became apparent that Cord Blood America Inc., could in fact be "The investment opportunity of a lifetime!"

Profile
Cord Blood America Inc. is the parent company of Cord Partners, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and life-saving resource for treating a growing number of ailments, including cancer, leukemia, or blood and immune disorders.

Cord Blood Banking
Cord blood banking is the process of collecting the blood from a newborn's umbilical cord immediately after delivery and cryogenically storing it for future potential medical uses. Because the collection occurs after the cord has been clamped and cut, there is no risk or pain to the infant or mother. Thousands of families are banking their newborns' cord blood because it contains stem cells that are unique to the newborn, and genetically related to their families.

Cord Blood Stem Cells - The Best Kept Medical Secret
With cord-blood research there is not only a potential, but a here-and-now workable medical reality. Adult stem cells which include umbilical cord cells are far superior to embryonic stem cells regardless of how the embryos are created. And because they are obtained from tissue discarded after a baby is born, umbilical cells are free of the political controversy surrounding embryonic cells.

While embryonic stem cells to date have yielded absolutely no successes and 0 clinical trials, adult stem cells, which include umbilical cord blood stem cells, have been successfully used to treat over 70 conditions, including brain and many other cancers, multiple sclerosis, Crohn's disease, rheumatoid arthritis, sickle cell anemia, stroke, limb gangrene, corneal regeneration, heart damage, Parkinson's disease and spinal cord injury.

Large and Growing Market
The market for private cord blood preservation has been estimated at $125 million in the U.S. in 2004, penetrating 3.5% of the approximately 4 million annual births, uup from roughly 1.9% in 2003. Based on industry estimates, the company expects the market size to grow to in excess of $1 billion per year, as market awareness increases and the applications of stem cell therapeutics broaden.

Incredible Revenue Growth
On November 30th, 2004 CCEL.OB a direct competitor of Cord Blood America Inc. which has traded for several years, reported annual revenue of approximately $12.2 million. On our about that time CCEL's share price and market-cap reached $6 and $66 million dollars, respectively.

Cord Blood America Inc. (CBAI: OTCBB) is expected to report annual revenues this year of approximately $4 million a 500% increase over 2004. They also expect to grow revenues to $10 million in 2006. Nine consecutive quarters of revenue growth leaves little doubt that the company will achieve this goal! In fact there are very few small cap companies that exist today that can boast such an incredible revenue growth record.

It is reasonable to suggest that a company in the same industry producing similar results and exceptional revenue growth would also achieve a similar market cap. With an outstanding share count of 33 million shares we would expect the share price of CALB.OB to reach $2 in 2006 or a 1000% gain from the current share price.

Stem Cell Legislation
Stem Cell Therapeutic and Research Act Of 2005 (HR-2520) Passes The House Of Representatives

On Tuesday May 24, 2005, the House of Representatives, by a virtually unanimous vote, passed HR-2520, a bill that would boost research using adult stem cells, bone marrow, and cells from umbilical cord blood. Opponents to a similar but controversial embryonic bill embraced HR-2520 for its focus on stem cells from umbilical cords. While President Bush states he will veto the embryonic bill, the White House fully supports HR-2520. The legislation will provide $79 million in federal funding to increase the number of cord blood units available for matches.

Once passed the legislation is expected to greatly increase public awareness on the value of cord blood stem cells. As research utilizing cord blood cells emerges to successfully treat diseases that afflict vast portions of the population, it will further enhance the perceived future value of cord blood stem cell preservation and increase cord stem cell banking.

Within a few days of after the announcement, the share price of CBAI.OB surged on record volume!. In July, investors could be in for another upside share price leap as the HR-2520 is expected to easily pass the Senate where majority leader Bill Frist is looking to schedule a vote as soon as possible.

Summary
This is only the beginning of what is already perceived by the international community to be a Biomedical Revolution. The entire world is closely following the advances in stem cell research, and everyone is interested in the potential of stem cells to treat everything from diabetes to Parkinson's diseases. The most exciting thing may be what we do not know today. With every new medical discovery and application of Cord Blood Stem Cells; doctors, patients, and investors will be all ears. As more families discover the unprecedented benefits of storing the cord stem cells of their new born, the client base will continue to grow dramatically and the shareholder value of CBAI.OB will grow proportionately.

We are riding on the "coat-tails" of a Biomedical Revolution and this in fact could be "an investment opportunity of a lifetime." CBAI.OB shareholder gains may continue to be realized for years to come.

Happy Trading!

Safe Harbor Disclosure:
Any and all DanceswithBulls.com stock profiles contain or incorporate by reference "forward-looking statements," including certain information with respect to plans and strategies of the featured company. As such, any statements contained therein or incorporated therein by reference that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words "believe(s)," "anticipate(s)," "plan(s)," "expect(s)," "project(s)" "anticipate(s)" and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause actual events or actual results of the Companies profiled herein to differ materially from these indicated by such forward-looking statements.

Posted by Industrial-Manufacturing at 01:34 AM | Comments (0)

One of the world’s foremost heart institutes is being built on the success of the heart transplant program.

In this video interview, Dr. Dennis Modry, a leading cardiologist and heart transplant specialist, discusses the unique concept of the Alberta Heart Institute.

Edmonton, Alberta, Canada (PRWEB) June 29, 2021 -- In 1985, Dr. Modry implemented Western Canada's first heart and lung transplantation program. Today, the Capital Health Authority’s Heart and Lung Transplantation Program is the largest and most successful in Canada, and one of the largest in North America. The success of the Heart and Lung Transplant Program set the stage for the implementation of the very successful Liver Transplantation Program, which facilitated the subsequent development of the renowned Islet Cell Transplant Program known as the Edmonton Protocol.

The longest survivors of the cardiac transplant program have received their new heart almost 20 years ago. “We’ve transplanted individuals from 12 hours of age to 79 years of age, including the oldest person in the world to have had a transplant. So, I think we have a record at both ends of the age spectrum … the youngest and the oldest” says Modry. He expects that as the Alberta Heart Institute’s reputation grows and its outcomes become better known, even more people will come to the Institute.

The Mazankowski Alberta Heart Institute is a new centre of cardiac excellence dedicated to cardiology, cardiac surgery, transplants, diagnostic testing, research and education. The Alberta Heart Institute’s location is uniquely positioned to draw upon the interdisciplinary specialities of the Stollery Children Hospital, the University of Alberta Hospital, and a the new Alberta Cardiovascular Stroke Research Centre (ABACUS). The ABACUS will open later this year, leading to the opening of the Mazankowski Alberta Heart Institute in 2007. The Alberta Heart Institute will serve the Edmonton region, Alberta, Western Canada, the Canadian North and many other regions as it is being built with an excess capacity in mind.

With $156 million from the Alberta government and more than $35 million in private donations raised through a capital campaign, the Institute will cut waiting lists for heart treatment and ensure access to leading edge technology. Dr. Modry emphasizes that this will eventually lead to new research discoveries and will take us into the tomorrow.

The Institute has a major focus on prevention of heart diseases and the development of novel diagnostic and therapeutic strategies. “We believe that this concept will make the most dynamic heart institute in the world because we will be able to transfer our research in prevention, in diagnostic and in therapeutic immediately to clinical care” says Dr. Modry. “This will benefit patients as they will be exposed not only to leading edge and state of the art technologies, but will receive high degree of interdisciplinary clinical care.”

Dr. Modry suggests that pretty much everything can be transplanted, except “we’re not there with respect to brain, teeth, whole eyes… but specifically, skin, bones, joints and limbs could be and have been transplanted, even faces. Organs such as lungs, hearts, kidneys, liver, intestine, heart valves and many other organs can be transplanted. We’re pretty much recyclable.”

The mapping of the human genome has engendered a whole new field of research focused toward gene therapy and rebuilding hearts. Dr. Modry believes that at some point, we won’t need to place mechanical devices in the heart as or even doing heart transplant in the future … “maybe it’s just going to be a matter of gene therapy”.

It’s exciting to contemplate how this institute will not just foster research, education and clinical care, but will also be an economic engine for the region. It will attract a high degree of skills and employment, and as it has been build for excess capacity, the institute will be able to provide care for patients from Canada and other areas of the world.

"It's a team work building on the success of the Capital Health and the University of Alberta's cardiac programs” says Dr. Modry.

- 30 -

Media enquiries may be directed to:
Julien Lambert
MyHealthVideo.com
Ph: 780-498-6306
e-mail protected from spam bots

Posted by Industrial-Manufacturing at 01:33 AM | Comments (0)

June 27, 2021

Recharge Your Spirit

Do you wish you could go to bed every night listening to the sound of wind rustling through trees or the gentle swish of the ocean surf? White noise - a steady, monotonous stream of the same peaceful sound - can filter and mask distracting noises.

(PRWEB) June 27, 2021 -- Do you wish you could go to bed every night listening to the sound of wind rustling through trees or the gentle swish of the ocean surf? Unfortunately, modern life is busy and noisy, and it can be hard to switch off from all the sounds outside. Now, though, research has found a solution which can help you wind down and have a peaceful nights rest. One paper called it “simple, safe, cost effective” (Note 3).

White noise - a steady, monotonous stream of the same peaceful sound - can filter and mask distracting noises. It can calm you and help you relax. Try white noise to:
- mask disturbing sounds such as traffic, TV, snoring or noisy neighbours
- relieve insomnia, sleeplessness or restlessness and wake refreshed
- help you concentrate if you work in a noisy open plan office
- improve study skills, by blocking out distractions
- aid with treatment of dizziness, vertigo, colic and tinnitus
- calm pets disturbed by sudden noises.

What people say:
We live next to a busy road and right next to an airport…I play the soothing airconditioner CD every night on repeat- and I no longer get woken up by cars or air traffic. I used to suffer from insomnia- but not any more! Angie A, Bedforshire

I'd just like to compliment you on the sound quality and effectiveness of your white noise CDs, Distant Thunderstorm and Restful Rain… are ideal listening while studying intently in a distracting environment and are perfectly relaxing in their own right. Really worthwhile purchase. Richard S, Dorset
Your wonderful babys vacuum CD has truly been a blessing for us. We play it each night and our daughter seems to love it. She has cried less and slept longer. Laurie B., Middlesex

Our White Noise CDs are carefully recorded, re-mixed and digitally mastered to create white noise at its finest. By playing our white noise on your CD player, you’ll have full control over the sound such as volume and tone to customize its benefits for your individual situation or mood. You can sample and buy these White Noise CDs from yourfavouriteshop.com with prices starting from €11.99/£8.49
## Ends ## June 2005

Editors Note
1. For press enquiries, contact Antonia Chitty at ACPR 18 Spencer Mews London SW8 1HF Telephone: 020 7820 7768 Mobile :07900 580668 Email: e-mail protected from spam bots
2. YourFavouriteShop.com184 Rathmines Rd Lwr - Suite 1Rathmines, Dublin 6 Ireland
3. Research into white noise:
Hawaii Med J. 2002 Sep;61(9):192, 213.Evidence based complementary intervention for insomnia. Lopez HH, Bracha AS, Bracha HS.
Increasing scientific evidence points to a non-pharmacological complementary treatment for insomnia: white noise. Its presentation has been shown to induce sleep in human neonates and adults, probably by reducing the signal-to-noise ratio of ambient sound. White noise may be a simple, safe, cost-effective alternative to hypnotic medication in many psychiatric disorders, especially acute stress disorder and PTSD.

Int Tinnitus J. 2004;10(2):150-5.Sequential sound therapy in tinnitus. Lopez-Gonzalez MA, Lopez-Fernandez R.
Benefits were found from white noise therapy for all patients in the study group.

Posted by Industrial-Manufacturing at 05:09 AM | Comments (0)

Foundation Hosts Telephone Conference on Deferiprone Oral Iron Chelator

Deferiprone is an alternative drug for treating thalassemia, a genetic blood disease. The treatment can be obtained under the FDA's Treatment Use Program and may provide additional cardioprotective benefits.

(PRWEB) June 25, 2021 -- The Cooley’s Anemia Foundation (CAF) hosted a special telephone conference on June 21 to discuss deferiprone, an oral iron chelator that offers a possible alternative to people suffering from the fatal genetic blood disease, thalassemia. The call focused on information about the drug, including its cardioprotective aspects and its current availability to some patients under the Food and Drug Administration’s Treatment Use Program.

Individuals born with thalassemia major (a.k.a. Cooley’s anemia) require lifelong blood transfusions every two to four weeks. These transfusions result in a deadly build-up of excess iron in the body; left untreated, this excess iron results in heart and liver failure. At this point in time, the only FDA-approved treatment for this iron overload is deferoxamine, a drug that must be delivered nightly via infusion over an 8 to 12 hour period.

Because this method of administration is so burdensome, few patients can maintain the optimal treatment, resulting in an unacceptable level of mortality among the patient population. An effective oral chelator, which would be easier to administer, is desperately needed to stop premature deaths among these patients. Deferiprone, which is in use in 48 countries but is not yet approved for general use by the FDA, is one possible alternative, especially as there are indications that it may have greater cardioprotective benefits than deferoxamine.

The telephone conference was moderated by Dr. Elliott Vichinsky, Director of the Thalassemia Program at Children’s Hospital Oakland. Speakers included Dr. Alan Cohen, head of the Thalassemia Program at Children’s Hospital of Philadelphia; Dr. Antonio Piga, of the Department of Pediatric Hematology at the University of Turin, Italy; Dr. Dudley Pennell, cardiologist with Royal Brompton Hospital and Imperial College, London; and Maria Hadjidemetriou, a thalassemia patient with experience using deferiprone.

Among the information presented during the call:

- Prospective studies have demonstrated that deferiprone is a viable treatment option for patients with iron overload, especially if they cannot obtain acceptable results using their current therapy.

- Some patients may develop side effects ranging in severity from rare cases of agranulocytosis to joint problems and gastrointestinal disturbances; however, careful monitoring of the patients and modification of their treatment can minimize the risk of these side effects.

- Several studies indicate that patients using deferiprone, either alone or in combination with deferoxamine, may experience a greater and more rapid reduction of cardiac iron.

- Some thalassemia patients who appear to be well-chelated with deferoxamine may still develop cardiac problems. For that reason, it is recommended that patients avail themselves of T2* technology, a new method of measuring cardiac iron stores, to better ascertain potential risk of heart disease.

- Although deferiprone is not currently available to the general population in the United States, doctors can utilize the FDA’s Treatment Use Program to obtain the drug for those patients whom it would benefit.

Peter Chieco, CAF Vice President for Medical Information, stated that “there is a crucial need for an alternative treatment for people with thalassemia. We believe that deferiprone is one such alternative. While we are grateful that this drug is available to some patients through the Treatment Use Program, we reiterate the need for ready access of deferiprone for the general thalassemia population.”

Founded in 1954, the Cooley’s Anemia Foundation is the nation’s leading nonprofit organization dedicated to fighting thalassemia. The Foundation provides valuable patient services, funds important medical research, educates medical professionals about the latest advances in thalassemia and spreads awareness of the disease among the general public.

For more information, contact the Cooley’s Anemia Foundation at 800-522-7222.

Posted by Industrial-Manufacturing at 05:08 AM | Comments (0)

Perfect Traveling Medication Reminder

e-pill device featured on NBC Today Television Show

Wellesley, MA (PRWEB) June 25, 2021 -- e-pill, the leading provider of medication reminder products, had its e-pill Multi-Alarm Pill Box featured on NBC Today Television Show.

Under the title “Forever Young” NBC Today’s Jim Miller featured helpful gadgets for older travelers.

Americans over the age of 50 make up almost 80 percent of all leisure travel spending. But for those who suffer from physical limitations, travel can be difficult and frustrating. Jim Miller, editor of the Savvy Senior syndicated newspaper column, was invited on “Today” to share handy tips and gadgets that can help make your travel safer and easier.

The NBC Today show featured the e-pill Medication Reminder Multi-Alarm Pill Box (http://www.epill.com/multibox.html ) and goes on to call it: “The perfect traveling medication reminder! Helps you organize all your daily pills, and reminds you when to take them with a loud alarm that can alert you up to 37 times per day”.

“The e-pill Multi-Alarm Pill Box Medication Reminder is an innovative device that addresses important issues facing patients and healthcare professionals trying to improve medication compliance”, said Stefan Solvell, President of e-pill, “Taking the right medications and taking them on time”.

The award winning e-pill Multi-Alarm Pill Box is priced at $49.95 each and features an easy to set pill timer with up to 37 daily alarms and a slide out pillbox with safety lock. The e-pill Multi-Alarm Pill Box can be ordered on-line (www.epill.com) or by calling toll-free 1-800-549-0095.

e-pill products include pill organizers & automatic dispensers, electronic medicine reminders, multi-alarms, vibrating reminder watches, and compliance recorders. Prices begin at $24.95.

These are designed to lead to better medication management and patient compliance, a growing challenge in the health & medical field. Some startling statistics are as follows:
· 50% of all prescriptions are taken incorrectly
· 33% of patients take all their medications, 33% take some, 33% don't take any at all (Rx prescription never filled)
· 23% of nursing home admissions are due to non-compliance

For more information or to order any e-pill Medication Reminder, visit the website http://www.epill.com or call 1-800-549-0095 (+1-781-239-8255 from overseas).

Posted by Industrial-Manufacturing at 05:07 AM | Comments (0)

June 24, 2021

Tibetan Medicine May be the Answer to Alleviating Symptoms of Constipation

Padma Lax, a Tibetan formula is now available to help with healthy digestion and regular elimination. A case study shows a distinct improvement using Padma Lax along with more roughage and fluids.

Santa Rosa, CA (PRWEB) June 24, 2021 -- Constipation has an image problem. No one wants to talk about it yet everyone experiences it at one time or another. It is estimated that almost 50% of all individuals over the age of 65 years suffer from this condition, and it leads to considerable impairment of the quality of life. In addition, available medications that address this condition also have an image problem and are often viewed as harsh treatments. However, there is a revolutionary change taking place in terms of treatment options.

A recent case study conducted by Simon Feldhaus, M.D. demonstrates that the answer may lie in an ancient Tibetan formula incorporated into a nutritional supplement called Padma Lax. The study involved a 75-year-old woman suffering from chronically recurrent pain and gastrointestinal distress for over two years. The nature of the pain could not be precisely defined and was described as shooting or stabbing. Abdominal cramps, flatulence, a distended abdomen and irregular defecation with a marked tendency to constipation were also described. Apart from these symptoms, there were no previous illnesses or surgeries in the patient’s case history. Treatment included dietary advice which changed the patient over to a diet contain more roughage and fluids. Padma Lax was the only laxative used and with it came a distinct improvement. The symptoms had almost completely subsided within 6 weeks.

Isaac Eliaz, MD, an integrative physician in Northern California who also integrates Tibetan medicine into his practice recommends this product to his patients and believes that it is a gentle, natural way to regulate the gastrointestinal system: “Healthy digestion and regular elimination is one of the key components to health and wellness. It is a necessary component for maintaining one’s health and even a more important component when trying to recover from chronic illnesses.”

Medical experts say that it is not the infrequency of defecation alone that determines the severity of the condition, but also the side effects such as abdominal pain, bloating, increased passing of wind and the feeling of incomplete evacuation of the bowels. Constipation is in fact a mixture of symptoms that can be caused by the most varied pathogenic processes.

A working-group of the world gastroenterological organization Organization Mondiale de Gastro-Entérologie (OMGE), under the chairmanship of David Wingate, London stated in an article published in the Journal of Gastroenterology and Hepatology, that very often, various different disturbing factors are involved, such as diverticulitis with”slow- transit constipation“. An increased amount of roughage in the diet does not necessarily help here – in fact it helps in only every second case. Additional aggravating factors can be that the patients sit down too much, take too little exercise and are overweight.

The article also suggests that because of the very different causes of constipation, it is useful and practical, especially in elderly patients, to treat the constipation primarily “ex juvantibus”. Here, preference should be given to a laxative that not only has a mild action, but also has a broad spectrum of action, which means that it can have a positive effect on the digestion at various levels. Padma Lax qualifies as such a treatment.

About Padma Lax
The carefully balanced combination of herbs in Padma Lax helps promote and maintain proper digestive function and enhanced regularity. It is a natural choice for the relief of temporary constipation, such as that caused by change of diet, travel or stress.

About EcoNugenics
EcoNugenics offers premium nutraceuticals and dietary supplements based on the best of western science integrated with the wisdom of traditional and complementary therapies. Isaac Eliaz, M.D., L.Ac., a pioneer in the field of integrative medicine since the early 1980’s, founded EcoNugenics. Dr. Eliaz is a respected author, lecturer, researcher and clinical practitioner. He has been awarded several patents for his unique product formulations.

EcoNugenics focuses on two basic lines of dietary supplements: products that enhance the immune system and products that promote health and wellness. Media contact Constance St. John, 415-454-2243 or e-mail protected from spam bots.

Posted by Industrial-Manufacturing at 03:39 AM | Comments (0)

Emergency Congressional Oversight Urged to Prevent Illegal Action by US CODEX Delegation Next Month

Congress has been notified by the Natural Solutions Foundation that US CODEX policy, announced at a Public Hearing by the US CODEX Manager, conflicts with U.S. law. Two laws, the unanimously passed 1994 Dietary Supplements Health and Education Act (DSHEA) and the 1997 FDA Modernization Act (FDAMA) protect supplements from harmonization with international standards. US CODEX policy supports the restrictive Vitamin and Mineral Guideline (VMG) set for ratification with illegal U.S. assistance in Rome next month in direct violation of explicit US legal prohibitions. Congressional oversight is being urged to prevent illegal policy action by the US CODEX Delegation on behalf of this country.

(PRWEB) June 23, 2021 -- All members of Congress were notified by the Natural Solutions Foundation that the US CODEX policy, announced at the US CODEX Office Public Hearing on June 9, 2021 conflicts with two US laws which classify supplements as food (with no upper limits) and exclude them from harmonization with international standards. Because it is illegal, the US CODEX policy to support the VMG should be reversed immediately through Congressional oversight.

Three U.S. Congressmen, Reps. Paul, DeFazio and Burton, have already signed a Congressional Letter to Dr. Edward Scarbrough, the US CODEX Manager, urging him to bring US CODEX policy into alignment with US law, http://www.prweb.com/releases/2005/6/prweb250895.php.
On June 1, 2021 a Citizen's Petition, http://www.healthfreedomusa.org/petition/petition.pdf, a legal document designed to compel the US to follow its own laws, was submitted to the US CODEX Manager notifying him that support of the restrictive VMG violated Title 19, USC 3512 which prohibits the US from harmonizing with international standards which violate US law. Although presented as an Emergency Petition because of the forthcoming ratification of the VMG at the July 4-9 meeting of the Codex Alimentarius Commission, the US CODEX Office has not yet responded.

Interestingly, US CODEX policy in support of the VMG was announced over two weeks before the supposed completion of the US's policy decision-making process which Dr. Scarbrough believes will not be completed until next week. None the less, written and oral representations of the US's illegal intent to support the VMG were made by the US CODEX Office as early as two weeks ago at the public hearing. At that meeting, Dr. Scarbrough noted that public input had only a "theoretical possibility" of impacting US CODEX policy. However, Congressional oversight to ensure that Executive Branch Agencies, such as the US CODEX Office, support Public Policy as determined by Congress is expected to cause the CODEX Delegation to rethink its position.

The Natural Solutions Foundation, http://www.HealthFreedomUSA.org, is a leading voice in the health freedom movement in America.

Posted by Industrial-Manufacturing at 03:37 AM | Comments (0)

June 23, 2021

DDL West Package Engineer Named VP & Treasurer of New IOPP Chapter - Package Testing Lab Helps Form Southern California Division

DDL West today announced that Package Engineer, Michael Foster, has been appointed Vice President and Treasurer of the new Southern California chapter of the Institute of Packaging Professionals (IOPP).

Costa Mesa, CA (PRWEB) June 23, 2021 -- http://www.testedandproven.com/DDL-West.html – DDL West, a CA-based package, product and material testing laboratory, today announced that Package Engineer, Michael Foster, has been appointed Vice President and Treasurer of the new Southern California chapter of the Institute of Packaging Professionals (IOPP).

Foster, who has played an integral part in forming the Southern California IOPP chapter, will be responsible for the chapter’s financial records and budget development, along with assisting the President and Programs, Meetings and Publications Chair.

“The IOPP is the World’s largest packaging association,” said Foster. “With the Californian packaging industry continually expanding, Southern California really needs a chapter of its own.”

The Southern California Chapter will be the 51st Chapter of the IOPP, an association which currently has more than 5,000 members and 150 corporate members.

“DDL West is particularly excited to be involved in the development and management of the new IOPP chapter,” said Foster, “since the IOPP shares DDL’s commitment to serving the educational needs of the packaging community.”

For more information on the new Southern California IOPP chapter, visit: http://www.iopp.org/pages/index.cfm?pageid=152
For expert advice on package testing, visit http://www.testedandproven.com or call Mike Foster at (714) 979-1712 ext. 16.

About DDL West:
DDL West offers expert package testing, product testing and material testing services including Shock testing, vibration testing, tensile testing, leak testing and validation. DDL package testing clients find value through its zero-cost package testing consulting service, Pack-Advice. For more information, visit http://www.testedandproven.com or call Mike Foster at (714) 979-1712 ext. 16.

Posted by Industrial-Manufacturing at 03:55 AM | Comments (0)

June 22, 2021

Research and Markets : Analyzing the Medical Bed’s Market On a Global Basis Today

Research and Markets (http://www.researchandmarkets.com/reports/c19492) has announced the addition of Medical Beds Worldwide – A Market Strategy Report to their offering.

Dublin (PRWEB) June 22, 2021 -- Research and Markets (http://www.researchandmarkets.com/reports/c19492) has announced the addition of Medical Beds Worldwide – A Market Strategy Report to their offering.

Research and Markets (http://www.researchandmarkets.com/reports/c19492) has announced the addition of Medical Beds Worldwide – A Market Strategy Report to their offering

This report analyzes the market for Medical Beds worldwide. Topics discussed include product definition, application, rental market, technology, critical care beds, key players, recent product launches, and regulatory and reimbursement issues etc. The report provides detailed market estimates and forecasts for General Purpose Beds; Pediatric Beds; Birthing Beds; Specialty Care Beds/Systems (Air Fluidized and Low-Air-Loss, Bariatric, Critical Care, Mattress Systems); Electric/Powered Beds; Mechanical Beds; By Location (Hospitals, Nursing Homes, Other); Beds market by revenue source (Rental/Leasing, New Sales, Parts & Accessories, and Inspection & Maintenance Services) - by country and region.

Specific sections in the report include:
- Executive Summary
- Products and Applications
- Medical & Economic Issues
- Recent News and Market Developments
- Business Development Activities (M&A;, Partnerships, Alliances)
- Worldwide Market Estimates & Forecasts
- Our Analytical Framework
- Company Profiles
- Additional Resources
- Research Methodology

Regions Covered - The Americas (USA, Canada, Rest of the Americas - ROA); Asia-Pacific (Australia, China, India, Rest of Asia Pacific - ROAPAC); Europe (France, Germany, Italy, UK, Rest of Europe – ROE); Middle East & Africa.

Approximately 194 manufacturers and suppliers worldwide have been profiled.

The list includes:
ASI Medical; Bertec; Blue Chip Medical; Carital Ltd; Ergo Air; Centromed Ltd.; Etesmi; Famed-Zywiec Ltd; Gaymar Industries; Gendron; Giima; Ginevri; HARD Mfg.; Hausted (STERIS Corp.); Hawksley & Sons Ltd; Hill-Rom; Hoskins Medical Equipment Ltd; Huntleigh Healthcare; Invacare; James Consolidated; Joyce Healthcare; Karomed; Kinetic Concepts (KCI); Keisei Medical Industrial Co Ltd; LIC (Basis American Medical Products); LiftCare Bed; Linet; Lumex (Graham-Field); Major Lab; Malvestio; Marcon Group; Mason Medical; Matifas; MC Healthcare; Mediprema; Medisan; Medogar Technologies; Mellon Air Mfg; Merivaara Instrumentarium; Neuropedic; Ningbo David; NK Medical; Noa Medical; Pedicraft; Pegasus Airwave; Pegasus Egerton; Sanitaria Scaligera; Savion Industries; SenTech Medical; Shanghai Sanhe; Stryker; Sunflower Medical; Sunrise Medical; Talley Medical; Vail Products; Wissner-Bosserhoff.

For more information visit http://www.researchandmarkets.com/reports/c19492

Laura Wood
Senior Manager
Research and Markets
e-mail protected from spam bots
Fax: +353 1 4100 980

Posted by Industrial-Manufacturing at 07:00 AM | Comments (0)

Research and Markets: Analysis of the Blood-Flow Detectors and Flowmeters market on a Global Basis

Dublin, (PRWEB) June 22, 2021 -- Research and Markets (http://www.researchandmarkets.com/reports/c19498) has announced the addition of Blood Flow Detectors and Flowmeters to their offering

This report analyzes the market for Blood-Flow Detectors and Flowmeters worldwide. Topics discussed include product definition, application, technology, key players, recent product launches, and regulatory and reimbursement issues, etc. The report provides detailed market estimates and forecasts for Laser Blood Flowmeters; Electromagnetic Blood Flowmeters; Ultrasonic Blood-Flow Detectors and Flowmeters; Probes - by country and region. Specific sections in the report include:

- Executive Summary
- Products and Applications
- Medical & Economic Issues
- Recent News and Market Developments
- Business Development Activities (M&A;, Partnerships, Alliances)
- Worldwide Market Estimates & Forecasts
- Our Analytical Framework
- Company Profiles
- Additional Resources
- Research Methodology

About 90 manufacturers and suppliers worldwide have been profiled. The list includes:

Atys Medical, Advance Co Ltd., BioMedix, Cardiosonics (Neoprobe), Carolina Medical, Compumedics (DWL Elektronische Systeme), Cook Vascular, CooperSurgical, Elcat, Deltex Medical, Flowtronics, Gutmann Medizinelektronik, DE Hokanson, Huntleigh Healthcare, Kovenm/HADECO, LEA Medizintechnik, Medi-Stim, Nicolet Vascular, Oxford Optronix Ltd., Parks Medical Electronics, Perimed, Progetti, Sonotechnik, Spead Doppler-Systeme, Transonic System, Unetixs, Vasamedics and Vascular Technology.

Regions Covered - The Americas (USA, Canada, Rest of the Americas - ROA); Asia-Pacific (Australia, China, India, Rest of Asia Pacific - ROAPAC); Europe (France, Germany, Italy, UK, Rest of Europe – ROE); Rest of the World ROW (Middle East, Africa, Russia)

For more information visit http://www.researchandmarkets.com/reports/c19498

Laura Wood
Senior Manager
Research and Markets
e-mail protected from spam bots
Fax: +353 1 4100 980

Posted by Industrial-Manufacturing at 07:00 AM | Comments (0)

Research and Markets : Introducing a New Report With Vital Forecasts for Exhaled Gas CO2 Monitors and Transcutaneous CO2 Monitors - By Country and Region

Research and Markets (http://www.researchandmarkets.com/reports/c19510) has announced the addition of Carbon Dioxide Monitors Worldwide - A Market Strategy Report to their offering.

Dublin (PRWEB) June 22, 2021 -- Research and Markets (http://www.researchandmarkets.com/reports/c19510) has announced the addition of Carbon Dioxide Monitors Worldwide - A Market Strategy Report to their offering.

This report analyzes the market for Carbon Dioxide Monitors worldwide. Topics discussed include product definition; application; technology, key players, recent product launches, regulatory and reimbursement issues, etc. The report provides detailed market estimates and forecasts separately for Exhaled Gas CO2 Monitors and Transcutaneous CO2 Monitors - by country and region. Specific sections in the report include:

- Executive Summary
- Products and Applications
- Medical & Economic Issues
- Recent News and Market Developments
- Business Development Activities (M&A;, Partnerships, Alliances)
- Worldwide Market Estimates & Forecasts
- Our Analytical Framework
- Company Profiles
- Additional Resources
- Research Methodology

Approximately 67 manufacturers and suppliers worldwide have been profiled. The list includes:

Criticare Systems, Draeger Medical, GE Healthcare (Datex-Ohmeda), Invivo Research, IVY Biomedical, Linde Medical Sensors, Maquet Critical Care, Nellcor (Tyco Healthcare Group), Nihhon Kohden, Novametrix Medical Systems, Oridion, Perimed, Philips Medical Systems, Radiometer A/S (Radiometer America), SensorMedics, Siemens Medical, Smiths Medical, Spacelabs Medical, Sumitomo Electric, Thermo Electron Industrial Hygiene, Weinmann GmbH and Welch Allyn.

Regions Covered - The Americas (USA, Canada, Rest of the Americas - ROA); Asia-Pacific (Australia, China, India, Rest of Asia Pacific - ROAPAC); Europe (France, Germany, Italy, UK, Rest of Europe – ROE); Middle East & Africa.

For more information visit http://www.researchandmarkets.com/reports/c19510

Laura Wood
Senior Manager
Research and Markets
e-mail protected from spam bots
Fax: +353 1 4100 980

Posted by Industrial-Manufacturing at 06:59 AM | Comments (0)

June 21, 2021

Analytical Spectral Devices Inc. Receives Multi-System Order for RxSpec™ Drug Verification System Installation into VA Pharmacies

The RxSpec™ drug verification system incorporates patented technology in a pharmacy environment to examine a drug directly in the dispensing vial, and confirms that the correct drug and dosage are being dispensed. The RxSpec™ system uses advanced analytical and imaging technology to read the chemical composition and dosage of the drug, then compares the information with a drug ID library, and confirms quality compliance with FDA approved drugs.

Boulder, CO (PRWEB) June 21, 2021 -- Analytical Spectral Devices, Inc (ASD) announced today the receipt of orders for five RxSpec™ systems for use in the Veterans Administration’s high volume Consolidated Mail Outpatient Pharmacies. The RxSpec™ systems are an integral part of a large contract awarded to SI Baker of McKesson Corporation. Installation of the systems is scheduled for later in 2005.

The RxSpec™ drug verification system incorporates patented technology in a pharmacy environment to examine a drug directly in the dispensing vial, and confirms that the correct drug and dosage are being dispensed. The RxSpec™ system uses advanced analytical and imaging technology to read the chemical composition and dosage of the drug, then compares the information with a drug ID library, and confirms quality compliance with FDA approved drugs.

“This VA order is one more step in the pharmacy industry’s acceptance of the RxSpec™ approach to drug verification”, states Dave Rzasa, CEO and President of ASD. “The VA is the third major customer to purchase the RxSpec™ system since ASD and SI Baker/McKesson introduced RxSpec™ technology to the high volume Mail Order and Central Fill pharmacy markets last year. The fundamental value of RxSpec™ technology is the improvement in pharmacist productivity achieved by automating the prescription verification process, while at the same time ensuring that the correct drug is being dispensed.”

The RxSpec™ drug verification system is the only technology capable of directly examining and verifying that prescription drugs have the correct chemical composition and dosage. It has proven effective in distinguishing between drugs that look virtually identical, but which have, in fact, different formulations or dosages. This makes RxSpec™ technology a valuable tool for the prevention of drug dispensing errors and counterfeit detection. While RxSpec™ technology is currently available commercially for the high volume Central Fill and Mail Order pharmacies, ASD is currently developing versions for the Retail and Community Pharmacy markets.

Founded in 1990, Analytical Spectral Devices Inc. is an analytical instrument company specializing in Vis/NIR technology used for material identification and verification. ASD’s instruments perform well in a range of environmental conditions, and have applications in pharmaceutical, nutraceutical, analytical chemistry, mining, grain, food and dairy, remote sensing, and pulp and paper industries world-wide. ASD provides cost effective, user-friendly, research grade NIR technology for use in and out of the laboratory, for scientific and industrial users. For more information, please contact Amanda Griffin, Analytical Spectral Devices, 5335 Sterling Dr., Suite A, Boulder, CO, 80301; 303/444-6522, 303/444-6825 (fax); www.asdi.com.

Posted by Industrial-Manufacturing at 01:38 AM | Comments (0)

Laser Hair Removal - Finding The Best Laser For Safe, Effective, Affordable Hair Removal

Laser Hair Removal. Finding The Best Laser For Safe, Effective, Affordable Hair Removal. Medical Spa and Laser Hair Removal Expert in Raleigh, NC Provides Guidelines

(PRWEB) June 21, 2021 -- Laser Hair Removal. Finding The Best Laser For Safe, Effective, Affordable Hair Removal. Medical Spa and Laser Hair Removal Expert in Raleigh, NC Provides Guidelines.

Laser Hair Removal: A Guide to finding effective, safe fast and affordable laser hair removal treatments. Raleigh Laser Hair Removal and medical spa expert Kile Law Provides guidelines for choosing the appropriate Laser Hair Removal system.

Laser hair removal has come a long way since the first laser for hair removal received FDA clearance in the mid 1990’s. Older generation lasers were very slow, very painful and worked only on individuals with very dark hair and very light skin. Today, lasers can work on all skin colors and some lasers are even safe for treating tanned skinned.

Which laser to choose? -Spot size
The spot size of a laser determines how much skin area can be covered per laser pulse. Lasers with larger spot sizes (18 mm)can cover more area much more quickly. For example, a laser hair removal treatment of the back or full legs could take as long as 2 hours with older lasers. Today, these areas can be completely treated in less than 20 minutes. The spot size not only determines the speed and comfort of the treatment, but the efficacy as well. In the April 2004 issue of Derm Surgery, a peer reviewed medical study showed that lasers with an 18 mm spot size (exclusive to the Candela GentleLase www.candelallaser.com ) was more effective at removing hair than lasers with smaller spot sizes.

-Cooling systems
Each laser has a different way of cooling the skin. Some lasers use a topical cooling gel, others use a chilled tip. The most consistent, comfortable and safest way to cool the skin is with a Dynamic Cooling Device or DCD. Lasers equipped with a DCD cooling system are so effective in providing cooling to the skin that no topical numbing creams are necessary.

-Light Sources
Intense Pulsed Light (IPL) Systems are not lasers. They can remove hair, but recent peer reviewed medical studies show that most lasers are much more effective in treating unwanted hair than IPL systems

Choosing a Laser Hair Removal Center

Board Certified Physician
Many laser hair removal centers today operate without a physician. It is important to be certain that a board certified physician is on the premises or available in case of a concern. To determine whether or not a physician is board certified, go to www.abms.org. Board certified plastic surgeons can be found at www.plasticsurgery.org

Possible complications:
Complications with newer laser hair removal systems (built in 2002 or later) is not common, particularly if the laser is equipped with a Dynamic Cooling Device. It is important, however to determine how the laser clinic handles potential complications. Is there a physician available to examine the problem and prescribe medications if necessary?

Packages of treatments
Laser Hair Removal works on hair while it is in the growth phase only. At any given time, between 20% to 40% of the hair on any face or body area may be in a growth phase. Multiple treatments are required for complete clearance of the hair. However, each person may respond slightly differently. Laser hair removal centers should charge for just one treatment at a time. A reputable medical office or medical spa offering laser hair removal will offer individual treatments and not insist on payment of multiple treatments up front.

Pricing:
Because lasers for hair removal are much faster today than ever before, prices should be lower as well. An office offering laser hair removal can charge less for a laser hair removal treatment of the legs taking just 20 minutes vs. a 2 hour treatment with an older generation laser. Avoid centers offering “specials” on treatment packages, particularly if there is pressure to buy because a "special" is set to expire.

Consultation:
A complimentary consultation should be available for you to visit the facility, meet the laser technician and experience a spot test with the laser.

When considering a hair removal laser treatment, consumers should ask the following questions:

1) Is this laser FDA approved for hair removal on my skin type and hair color?

2) What is the spot size of the laser? In order for a laser to perform quickly and most effectively, it should have an 18mm spot size

3) Is the laser equipped with a dynamic cooling device (DCD)? This is the safest and most consistent method of cooling the skin. It ensures patient safety and comfort.

4) Is there a board-certified physician on site? A facility without appropriate medical supervision may not be the safest environment for a laser procedure.

5) Are treatments sold in a package or one at a time? Businesses that want your money up front may not have the confidence that their laser will perform effectively. A client should be able to pay for treatments as needed without paying all at once.

6) Are complimentary consultations and spot tests available? You should be able to meet the technician and experience a pulse or two before committing to a treatment.

Blue Water Spa is a plastic Surgery Medical Spa owned and operated by board-certified plastic surgeon Dr. Michael Law. Blue Water Medical Spa offers laser hair removal, facials, microdermabrasion, chemical peels, massage, Botox, Restylane and the full spectrum of aesthetic surgery procedures performed by nationally known board-certified plastic surgeon Dr. Michael Law. Dr. Law has returned to his hometown of Raleigh North Carolina to raise his family after practicing aesthetic surgery in Beverly Hills. Dr. Law has been featured in many national magazines and interviewed for news programs, but he has declined invitations to participate in plastic surgery reality television programs. Blue Water Medical Spa and Dr. Law have received many "best of" awards in their area since opening their business in 2003.

Kile Law, president of Blue Water Spa was recently appointed to the 2005 board of directors for the National Day Spa Association www.dayspaaassocation.com. She is one of ten individuals nationwide chosen for this prestigious position. Kile is often a featured speaker at medical spa and skin care conferences. She is the winner of the 2004 ABBIES award http://www.abbies.org/2004winners.html for writing, one of the aesthetic industry's highest honors for a series of articles she wrote in Skin Inc. Magazine, www.skininc.com entitled "Starting from Scratch" Her articles documented the amazing success of Blue Water Medical Spa since opening. Blue Water Spa has been featured in cover articles of many national magazines http://www.bluewaterspa.com/media.html and spa publications such as the Medical Spa Report www.medicalspareport.com. An interview with Kile as part of a panel of recognized experts in medical spas and laser hair removal apeared in the November / December 2004 Issue Of Luxury Spa Finder Magazine. Luxury Spa Finder is the largest consumer spa magazine in the country.

For more information, go to www.bluewaterspa.com or michaellawmd.com.

Posted by Industrial-Manufacturing at 01:37 AM | Comments (0)

June 20, 2021

Austin Dermatologist Endorses Newly Approved Cellulite Treatment

Cosmetic dermatologist Dr. Daniel Ladd participated in clinical trials leading up to recent FDA approval.

Austin, TX (PRWEB via PR Web Direct) June 20, 2021 -- Cosmetic dermatologist Dr. Daniel Ladd of The Austin Skin Institute endorses the recently FDA-approved cellulite treatment Velasmooth, a revolutionary device that temporarily improves the appearance of cellulite. Dr. Ladd was one of the physicians who participated in the clinical trials leading up to the FDA approval.

"This device is truly one of a kind," explained Dr. Ladd, referring to the Velasmooth cellulite treatment combination of deep heat and massage delivered via radiofrequency, infrared and suction energies. "The deep heating mobilizes trapped fat while the massage increases circulation and allows for increased collagen production. All of these elements work simultaneously to mobilize stubborn fat pockets and increase skin smoothness."

Not only does the Velasmooth treatment improve cellulite appearance, but it actually reduces thigh circumference as well. "Patients love this body contouring and the slimming effect it has," Dr. Ladd added. "Patients also enjoy the fact that they can resume their normal activities immediately after the treatment sessions."

About Dr. Daniel Ladd
Dr. Daniel J. Ladd Jr., D.O. earned his BA at the University of Texas at Austin and received his medical degree from Des Moines University in 1999. As a leader in the field of dermatology, Dr. Ladd has been active in dermatologic research and has published in peer reviewed journals such as the Archives of Dermatology and the Journal of the American Osteopathic College of Dermatology. He is a member in good standing of the American Academy of Dermatology, American Osteopathic College of Dermatology, American Society of Dermatologic Surgeons and the American Society of Cosmetic Dermatology & Aesthetic Surgery.

About the Austin Skin Institute
The Austin Skin Institute is a state of the art dermatology facility that uses cutting edge medical technology and procedures to effectively treat a multitude of skin disorders through minimally-invasive aesthetic procedures and medical dermatology. For skin care problems such as acne, eczema, psoriasis, rosacea, skin cancer or warts, skilled dermatologist and Austin Skin Care's Medical Director Dr. Daniel J. Ladd Jr. uses an up-to-date approach to patient care. For more information about the Velasmooth cellulite treatment, visit www.austinskin.com

Media Contact:
Dr. Daniel Ladd
512-451-0139
e-mail protected from spam bots

Posted by Industrial-Manufacturing at 02:22 AM | Comments (0)

Prostate Cancer Patients Find Hope with Natural Remedy PC Hope

Research has shown and doctors are writing that for men with prostate cancer, Nutrition 2000’s PC Hope is associated with significant improvements in quality of life, reductions in patients’ pain rating, and a decline in PSA levels for prostate cancer patients without the major side effects of traditional treatment.

(PRWEB) June 20, 2021 -- Three books written by distinguished doctors indicate that an herbal supplement for prostate cancer patients by Nutrition 2000 called PC Hope, along with a comprehensive wellness plan, shows a lowering of PSA levels for prostate cancer patients and significantly reduces pain and improves the quality of cancer patients' lives.

The books were written regarding a remedy similar to PC Hope, called PC SPES. (“Spes” is the Latin word for hope.) PC Hope has the same eight herbs that were in PC SPES, plus the addition of magnesium, plant sterolins, and quercetin enhance the synergistic effects experienced by men who took PC SPES.

In the book by board-certified neurosurgeon Russell L. Blaylock, M.D., called “Natural Strategies for Cancer Patients,” he states that “PC SPES is a combination of eight highly concentrated Chinese herbs that have been found to be very effective against...prostate cancers. Its mechanism of action involves the inhibition of the systems used by the cancer cells for their growth and survival. It has been shown to inhibit cancer cell reproduction, suppress growth factors that contribute to the tumor growth, stimulate the p53 gene, and induce apoptosis in the cancer cells. Several clinical trials using PC SPES have shown the herbal combination to be a valuable option for patients with prostate cancer.” He also writes that of a group of prostate cancer patients tested, PSA levels remained low in 88% percent of them. In some prostate cancer patients, PSA levels fell to even undetectable amounts over time.

“'The Prostate Miracle' New Natural Therapies That Can Save Your Life” written by Jesse A. Stoff, M.D., a Certified Naturopathic Physician and a licensed Homeopathic Physician, and Dallas Clouatre, Ph.D., says, “The usual approach to treating prostate cancer is to treat the cancer, not the patient. PC SPES is different. The eight Chinese herbs have multiple effects that make this compound suitable to individuals whose health and basic constitutions vary widely…. [By acting as an antiviral, PC SPES may help to partially relieve the burden on the immune system. PC SPES also has anti inflammatory benefits, and these again, support the immune system and may help to inhibit one of the ways in which cancers spread and metastasize. Moreover, its actions against benign hyperplasia may serve to improve the quality of life, even aside from its effects upon prostate cancer itself and is another indication for its use that I employ in my practice.”

Chief medical correspondent for NBC News Dr. Bob Arnot writes in his book “The Prostate Cancer Protection Plan” about the stages of prostate cancer and how they are affected by PC SPES. “Dr. Eric Small studied 33 patients who were at late stage but were responsive to hormone therapy. He found 100 percent of these patients showed a more than 50 percent reduction in PSA and 74 percent had a more than 50 percent decrease in tumor volume.” Some patients who have progressive prostate cancer after undergoing hormone treatment are considered hormone-resistant cancer patients. The book cites a prostate cancer study in which “37 patients had hormone-resistant prostate cancer…. Still, even though many see PC SPES working primarily as hormone therapy, Dr. Small also saw a drop of about 50 to 60 percent in this group. This tells us that PC SPES has nonhormonal effects. Dr. B.L. Pfeifer reported a 70 percent reduction in PSA among his study patients….”

Again, although these books were written about PC SPES, PC Hope includes the same eight herbs that are in PC SPES, and provides greater results with its magnesium, plant sterolins, and quercetin.

Larry Pope, President of Nutrition 2000, says, “The results of these studies are promising and show that PC Hope is an effective alternative for prostate cancer patients. We want the public to be educated and know about the benefits of PC Hope. It is part of a comprehensive care program with a particular protocol, and should not be perceived as a magic bullet on its own.”

For more detailed information concerning these studies on prostate cancer, other cancers, or to learn more about PC Hope, please visit www.nutrition2000.com or call 1-800-558-9697.

About Nutrition 2000
Nutrition 2000 offers some of the world's finest natural health products, herbal remedies, alternative medicines, and supplements for the treatment of prostate cancer, pancreatic cancer, colon cancer, Candida, and more. Stocking a carefully selected range of products made from the highest quality herbal extracts and pharmaceutical-grade nutrient powders, they provide alternative natural remedies to combat illnesses and common ailments. Nutrition 2000 delivers their message and products to the United States, United Kingdom, and other countries around the world.

Posted by Industrial-Manufacturing at 02:21 AM | Comments (0)

June 17, 2021

AeroMed Products Can Help Healthcare Facilities with Bioterrorism Preparedness

The federal government, through HRSA, has made grant money available to healthcare facilities to prevent the spread of infectious disease resulting from a bioterror attack. AeroMed manufactures several models of HEPA air purifiers that may be used to create negative pressure isolation rooms which are required as a benchmark for participating in these grant programs.

(PRWEB) June 17, 2021 -- AeroMed, Inc. of Amsterdam, NY, is a leading manufacture of HEPA air purification systems for infectious disease control. AeroMed’s products are typically applied in applications involving tuberculosis and SARS control in health care facilities but may also be used in bioterror applications.

The federal government has determined that health care facilities may be at additional risk of nosocomial transmission of disease as the result of a bio-terror attack. The Health Resources and Services Administration (HRSA) has created the Bioterrorism Hospital Preparedness Program. According to HRSA’s web site “the goal of this program is to aid state, territory, and selected entities in improving the capacity of the health care systems, including hospitals, emergency departments, outpatient facilities, EMS systems, and poison control centers, to respond to incidents requiring mass immunization, isolation, decontamination, diagnosis, and treatment, in the aftermath of terrorism or other public health emergencies.” HRSA funds have been made available to health care facilities for the Bioterrorism Hospital Preparedness Program (see www.hrsa.gov/bioterrorism/index.htm).

Facilities awarded a HRSA grant, are required to meet specific benchmarks. One of benchmarks is the creation of negative pressure rooms for isolation surge capacity. HRSA states that “these rooms may be used to isolate suspected cases of a highly infectious disease (e.g., smallpox, pneumonic plague, SARS, influenza and hemorrhagic fevers) or febrile patients with a suspect rash or other symptoms of concern who might be developing a highly communicable disease.”

AeroMed manufactures many models of HEPA filter air purifiers that may be used to create negative pressure isolation rooms. These include portable and ducted units as well as wall and ceiling mounted units. The purifiers are used to treat 200 – 800 cubic feet per minute (CFM) of air exhausted from or recirculated within an isolation room. Several of the models are available with optional ultra violet (UV) lights as a supplement to HEPA filtration. AeroMed also provides room pressure monitors in order to comply with AIA (American Institute of Architects) recommendations, quantifying that negative pressure rooms are performing properly.

According to company president, Bill Palmer, many hospitals and health departments throughout the United States are already using these products for their isolation rooms. Palmer says that other products manufactured by the company such as their aerosol treatment chamber (sputum induction booth) are also used in health care facilities across the country.

Additional information regarding the use of these products to create negative pressure isolation rooms may be obtained by visiting the company’s WEB site at www.myAeroMed.com or by calling toll free 866-692-3766.

Posted by Industrial-Manufacturing at 02:08 AM | Comments (0)

June 16, 2021

ZyDoc Optimizes Olympus DS 4000 Professional Digital Recorder for e-Transcription Service

ZyDoc now features the Olympus DS 4000 Professional Digital Recorder for its award-winning e-Transcription service. Doctors improve productivity using the Olympus handheld recorder with intuitive slide controls and automatically upload dictations in seconds. ZyDoc software ensures HIPAA compliance and facilitates faster document turnaround with e-signature, browser-accessible secure Internet based records and automated download and printing of transcribed documents.

Hauppauge, NY (PRWEB) June 16, 2021 -- ZyDoc, an award-winning technology leader in transcription and automated medical documentation solutions, announced that it has upgraded and optimized its e-Transcription service to work with the Olympus DS4000 Professional Digital Handheld Recorder.

James M. Maisel, M.D., Chairman of ZyDoc says, “ZyDoc is delighted to expand our handheld digital recording options to the professional level with the release of the Olympus DS4000 unit. We have been working with Olympus since 1998 and have found their recorders to consistently offer excellent quality and value. The DS4000 unit allows doctors who prefer a classic slideswitch to benefit from the digital technology without change in habits. The ZyDoc software that extends the functionality of the digital handhelds and is licensed to a public transcription company has also been upgraded. The software had won a LISA business productivity award allowing the physician to easily and rapidly download dictations and resume work within seconds. No special computer skills are required since one mouse click handles all functions including downloading and archiving of the dictations from the unit before erasing them, packaging them, and securely transmitting them to ZyDoc where they are immediately available and tracked like a UPS package. The ZyDoc software also automatically connects to our secure servers, downloads all completed jobs and has them waiting in the printer in the morning for the doctor."

The company has over ten years of experience in working with physicians who want to document their medical encounters quickly and efficiently while getting high quality, fast turnaround, and specialized documentation. ZyDoc offers low risk, high productivity solutions featuring dictation for data capture involving no change in work habits, infrastructure costs or training. The web-based TrackDoc™ system offers substantial advantages to physicians over EMR alternatives and can be implemented in one day. These solutions are applicable for 100% of physicians and require no IT experience or internal support. ZyDoc solutions seem like a transcription service on the front end and have many of the advantages of an EMR. ZyDoc is suitable for a single practitioner, multi-site offices, ASU’s and hospitals and scales to a Community Health Information Network. The company exhibited at the first AMA Technology Summit on Selecting and Implementing the Right EMR technology in Philadelphia on November 12, 2004. Document access improves efficiency of coding and billing. Detailed medical records are easily shared and result in improved healthcare outcomes, especially in ambulatory environments involving multiple providers for complicated cases. The design eliminates the need for any capital investment and replaces legacy infrastructure.

Steve Koski, CEO and President of ZyDoc adds, "The ZyDoc technology platform offers a number of advantages to healthcare providers over traditional documentation solutions and EMR in terms of ease of implementation, operations, total costs, quality, speed of care, and disaster recovery. The solutions require no software or IT personnel, and are compatible with all PCs and operating systems with Internet browser capability. There is no training involved or complicated software to customize or learn. Doctors can start dictating immediately after enrollment using 800 toll free dialup or digital handheld recorders. Documents are always available on the Internet with HIPAA secure connections, and can be reviewed and signed remotely. The documents can also be automatically downloaded and printed to a PC, faxed or made available to share with authorized caregivers over the Internet. The ZyDoc carrier class data center has proven reliable without failure over the past year and was operational even during the Northeast blackout of 2003.”

Availability
The Olympus DS4000 unit is immediately available from the ZyDoc Website Store http://www.zydoc.com/Merchant2/merchant.mv?Screen=SFNT&Store;_Code=ZOS. Physicians can enroll for a free trial of the ZyDoc e-Transcription and TrackDoc™ EMR system directly on the secure http://www.zydoc.com/freetrial website or contact ZyDoc support at 631-273-6125. Physicians currently using the TelDoc™ 800 service can contact ZyDoc support to immediately upgrade to digital handheld recorders. Transcription ASP infrastructure solutions are also available to replace legacy and non-HIPAA-compliant services for transcription companies or hospitals that need infrastructure support. ZyDoc provides multimedia demonstrations, training, and support via the Internet at http://zydoc.webex.com and through an expansive nationwide network of Tech Data, Toshiba, and qualified integrators. For more information on ZyDoc Automated Medical Documentation Solutions visit www.zydoc.com.

About ZyDoc.com Corporation
ZyDoc is a transcription service and software development company providing e-Transcription, automated electronic health record (EHR) documentation and infrastructure ASP legacy-replacement solutions. Physicians, transcriptionists, and other healthcare professionals use these services to produce, organize, and distribute multi-specialty patient electronic medical records (EMR) in Community Health Information Networks (CHIN). ZyDoc solves the PC literacy, data entry bottleneck, implementation, and cost issues that plague other clinical documentation and transcription companies. The company uses transparent embedded technology that leverages front- and back-end speech recognition, workflow enhancements, and the Internet. ZyDoc is a development partner with SUNY Computer Sciences at Stony Brook, a Microsoft Solutions Partner, a ScanSoft Platinum Dealer, and an IBM Speech Premier Business Partner. In 2004, ZyDoc was ranked third nationally in medical transcription by The Medical Records Institute and was named the Healthcare Tablet Application of the Year.

Press Contacts:
James M. Maisel, M.D.
Chairman, ZyDoc.com
ZyDoc.com Corporation
631-273-1963
SOURCE: ZyDoc
Website: www.zydoc.com

Posted by Industrial-Manufacturing at 10:06 PM | Comments (0)

Specialty Drug Spending Continues to Grow According to New Knowledge Source Market Overview

Knowledge Source’s Specialty Pharmacies Market Overview reveals that specialty drug spending continues to grow at a rapid pace, driven by increased use of an expanding array of medications. The report further states that the number of biotech drugs in development has grown from 100 in 1990 to approximately 600 in 2005 and the estimated size of the market has grown to approximately $40 billion in 2005 with market size projections reaching nearly $75 billion in 2008. This report, and company-specific BusIntell Reports, are available online at www.knowsource.com

Trumbull, CT (PRWEB) June 16, 2021 -- Knowledge Source, Inc. (www.knowsource.com) announced today that it has published a market overview on Specialty Pharmacies available online at www.knowsource.com (http://www.knowsource.com?refer_id=2931) or by calling 203-377-0460.

Knowledge Source's Specialty Pharmacies Market Overview, 250 pages in length, includes the Market's Overview and Trends, as well as brief profiles of over thirty-five of the major industry participants which include (when available): company background, company strategy, products and services, financial information and recent activities.
http://knowsource.ecnext.com/coms2/summary_0233-203_ITM?refer_id=2931

The company also announced that company-specific BusIntell Reports are also available online. These reports provide a comprehensive strategic analysis of the leading Specialty Pharmacies, including AmerisourceBergen, Cardinal Health, Caremark Rx, CIGNA Pharmacy Management, Express Scripts, McKesson, Medco Health Solutions, PharmaCare, Prescription Solutions, Prime Therapeutics, Walgreens and WellPoint.
http://knowsource.ecnext.com/coms2/browse_B?refer_id=2931

For additional information on the Specialty Pharmacies Market Overview or other research reports published by Knowledge Source, please contact John Santilli at 203-377-0460 or visit Knowledge Source at http://www.knowsource.com?refer_id=2931. This Market Overview report is 250 pgs in length and purchasable for $345 with immediate online delivery.

About Knowledge Source
Knowledge Source, a national business intelligence and market research firm, has delivered healthcare business information and analyses services to executives who seek a competitive edge since 1989.

Knowledge Source provides healthcare information, syntheses, analysis and presentation services to busy managers who seek actionable market knowledge about clients, competitors, industries or markets in a world with an over-abundance of data.

Posted by Industrial-Manufacturing at 10:05 PM | Comments (0)

June 15, 2021

This Father’s Day Treat That Special Senior Dad to the Gift of Independence and Peace of Mind with a Lifeline Medical Alert

Change holder for dresser: $12. Best seller new release: $24. Tie: $35. Giving Dad the ability to continue living on his own and in his own house: priceless.

Framingham, MA (PRWEB) June 15, 2021 -- On Father’s Day, the day set aside for men ranging from new dads to great grand dads, some special men with senior status deserve a gift with value substantially more than that of a tie, money clip or new gardening tool. The gift of a special pendant or wrist band, a Lifeline personal help button, allows these older men to continue to live safely and independently in their own home, surrounded by the security and stability they have built over time. By bringing a Lifeline personal emergency response system into their home, many older men are able to put off the difficulty and frustrating of having to leave their treasured collections, established routines, gardens, friends and pets behind when they must move to an assisted living facility or nursing home.

Lifeline Systems has been the leading provider of personal response services in the United States for over 30 years. Lifeline is the preferred provider of medical alert services to members of the Visiting Nurses Associations of America, and to thousands of leading doctors and hospitals. In addition, the Lifeline service is available through select chapters of the American Red Cross.

With the simple press of a waterproof button, at any time of the day or night, the user is quickly connected with a highly trained Lifeline Personal Response Associate. The Associate makes voice contact through the Lifeline speakerphone, reviews the individual's personal and medical profile, assesses her situation and then notifies a family member, neighbor, or appropriate support and medical response team as the situation requires.

“After my mom died my sisters and I were certain that our Dad would want to move into a nearby assisted living facility to be with his brother and to eliminate any extra house work and maintenance,” writes a daughter of a Lifeline subscriber. “While he was terribly sad that my mom wasn’t around, my Dad is a proud man and insisted that he be able to stay in his home of 37 years. He told us he was not going to move away from the town he’d grown up in and leave the life he’d established there. The social worker at the hospital suggested that we look into Lifeline. It has offered us the perfect solution giving dad his freedom and ability to stay at home and has given us the comfort of knowing he can press a button and Lifeline will alert us as well as get him immediate help if he needs it.”

Lifeline personal response and support services offer:

- Immediate response by caring and highly-trained Personal Response Associates—24 hours a day/365 days a year
- State-of-the-art equipment made by Lifeline
- Lightweight, waterproof personal help button that can be worn as a pendant or on the wrist
- CarePartner Telephone option with larger number buttons and personalized reminders
to help manage medications, diet, exercise and appointments
- No minimum service commitment, all at a cost of little more than a dollar a day

For more information about getting a Lifeline medical alert for dad in time for Father’s Day, visit www.lifelinesystems.com, or call 800-380-3111.

About Lifeline Systems, Inc.:
Established in 1974, Lifeline Systems is the leading provider of personal response services and emergency call systems in the United States and Canada. As of March 31, 2005, the Company supported more than 433,000 subscribers from its response centers in Massachusetts, Ontario and Quebec. Lifeline also supplies emergency response equipment and services to owners and developers of independent living, assisted living and continuing care retirement communities across North America. To people who live alone or in senior living communities, the Company provides reassurance and peace of mind with dedicated, well-trained people, advanced technology and a nationwide support structure to achieve service excellence. The Company is committed to affording its subscribers and residents the dignity, privacy and respect to which they are entitled. For more information about Lifeline Systems, visit www.lifelinesystems.com.

Contact:
Elise B. Hamann
401-884-7976



Posted by Industrial-Manufacturing at 07:11 AM | Comments (0)

Internationally-Renowned Cardiologists/Cardiothoracic Surgeons Form Medical Society Focusing on Heart Valve Disease

Heart Valve Society of America (HVSA) formed to promote education and research and advance recognition & knowledge of field.

(PRWEB) June 15, 2021 -- The Heart Valve Society of America (HVSA) — including the Heart Valve Trialists Society — has been formed by a founding board of nationally and internationally prominent cardiologists and cardiothoracic surgeons in the heart valve disease field.

The mission of the Society is to:
- promote research
- educate medical professionals about the evaluation and treatment of heart valve diseases;
- serve as an informational resource for government, private industry, healthcare providers, the media and public; and,
- encourage and facilitate education of future heart valve disease specialists

"Heart valve diseases can be considered 'mystery killers,'" said Jeffrey S. Borer, MD of Weill Medical College of Cornell University, president of the Society. "Too often, they progress slowly and imperceptibly, yet are capable of causing sudden and unexpected death. The founding board believes a vehicle is needed to bring cardiologists, cardiothoracic surgeons, anesthesiologists, pathologists, internists, basic scientists, other medical and allied health professionals together, in order to further research and educate caregivers and patients about this important public health problem."

Please visit our site at www.heartvalvesocietyofamerica.org

The founding board members include:
Jeffrey S. Borer, MD (President) — Gladys & Roland Harriman Professor of Cardiovascular Medicine, Chief, Division of Cardiovascular Pathophysiology and Co-director, The Howard Gilman Institute for Valvular Heart Diseases, Weill Medical College of Cornell University

Maurice E. Sarano, MD (Executive Vice President) — Professor of Medicine, Mayo Medical School; Director, Valvular Heart Disease Clinic, Mayo Clinic

A. Jamil Tajik, MD (Secretary) — Thomas J. Watson, Jr. Professor, Mayo Medical School; Consultant, Cardiovascular Diseases, Mayo Clinic

Mark Starling, MD (Treasurer) — Medical Director, Banner Baywood Heart Hospital, Mesa, AZ

Cary W. Akins, MD (Vice President/Interspecialty Liaison) — Clinical Professor of Surgery, Harvard Medical School; Chief, Division of Cardiac Surgery, Massachusetts General Hospital

Robert O. Bonow, MD (Vice President/Membership) — Goldberg Distinguished Professor of Medicine and Chief, Division of Cardiology, Northwestern University Medical School; immediate past president, American Heart Association

Blase Carabello, MD (Vice President/Programs & Education) — The W.A. “Tex” and Deborah Moncrief Jr. Professor of Medicine, Baylor College of Medicine; Vice Chairman, Department of Medicine, Baylor College of Medicine

O. Wayne Isom, MD (Vice President/Interspecialty Liaison) — Terry Allen Kramer Professor and Chairman, Department of Cardiothoracic Surgery and Co-Director, The Howard Gilman Institute for Valvular Heart Diseases, Weill Medical College

Jagat Narula, MD (Vice President/Policy) — Professor of Medicine, Chief of Cardiology, Associate Dean, University of California/Irvine

Since receiving its nonprofit status in late October 2004, HVSA membership has grown to close to 200 members. In April, the Society had it first annual meeting and conference at Valves in the Heart of the Big Apple IV: Evaluation & Management of Valvular Heart Diseases 2005 in New York City. Almost 350 participants from the US and abroad attended the two and one-half day conference, which featured top presenters in the field.

Membership is open to medical and allied health professionals involved/interested in the field, as well as individuals who work for corporations, academic and service institutions, and foundations interested in valvular heart disease.

Posted by Industrial-Manufacturing at 07:09 AM | Comments (0)

Spiral Biotech Introduces Color QCount Bacterial Colony Counter with ColorCount Technology -- First System with Quick Setup and Adjustment-Free Color Operation

Spiral Biotech, a leader in microbiology solutions for food, dairy, and environmental sciences, today introduced the Color QCountTM bacterial colony counter with new ColorCountTM recognition technology.

Norwood, MA (PRWEB) June 15, 2021 –- Spiral Biotech, a leader in microbiology solutions for food, dairy, and environmental sciences, today introduced the Color QCountTM bacterial colony counter with new ColorCountTM recognition technology.

“Our new ColorCount technology gives the Color QCount the easiest set-up and operation of any color colony counter in the industry,” said Anthony Pappas, product manager, Spiral Biotech. “Up and running in minutes, its intelligent software instantly recognizes color variations and does not require complex and time consuming manual adjustments to make it perform effectively. In addition, users have the flexibility to easily define their own color settings,” Pappas said.

The instrument is exceptionally accurate and is designed to work with the new chromagenic agars becoming popular for high-productivity colony counting that involves multiple strains of bacteria. “The Color QCount is ideal for demanding food and pharmaceutical research applications where high throughput and precise identification of microorganisms, such as Salmonella, Listeria, and E.coli, are essential,” he said.

The instrument features a high-resolution digital CCD camera that captures a minimum colony detection size of 0.15mm. It also comes with a flexible data management system that saves each plate image in its database for printing and re-analysis. The user can manually exclude areas and add or delete colonies and the system’s software will recalculate colony forming unit data and flag it to indicate manual editing. The system compiles and captures data in a GLP-compliant format. Data can be saved as a spreadsheet and archived to a CD-ROM to satisfy any regulatory or auditing requirement.

The ColorCount technology package also is available as an upgrade for existing Color QCount systems. The instrument comes with a one-year warranty and is available for immediate delivery.

On the Net: http://www.spiralbiotech.com

About Advanced Instruments
Founded in 1955, Advanced Instruments, Inc. is the world’s largest supplier of freezing-point osmometers used in clinical, pharmaceutical, and biotechnology laboratories. The company is also a leading supplier of analytical instruments and test kits for the food, dairy, and industrial microbiology markets. Based in Norwood, Massachusetts, USA, the company also produces Fiske® Associates brand diagnostic instruments and operates Spiral Biotech, Inc., and Delta Instruments as wholly-owned subsidiaries. Advanced Instruments’ products are supported by a worldwide network of direct sales people and independent distributors. The company can be found online at www.aicompanies.com or contact customer service at 800-225-4034 or +1-781-320-9000.

Posted by Industrial-Manufacturing at 07:08 AM | Comments (0)

No more Broken Segway Kickstands - Segway of Oakland Offers World’s only Unbreakable Kickstand

Segway of Oakland is world-renowned for selling unique after-market Segway HT accessories and creating slick customized models no one else could even dream of, let alone usher into reality.

(PRWEB) June 15, 2021 -- The Segway rental and sales dealership located at 212 International Blvd. near Lake Merritt in Oakland uses a combined 12 years of Segway experience and knowledge to surprise the nation and the world with its latest designs, such as the Heavy Hauler, Segway Polo Master, OT and EMT models. The Polo Master gained attention in a recently televised Bay Area Fox News segment, while the EMT model has appeared in publications and websites from as far away as Europe and South Africa.

Possibly the most sought-after item in the cool, ‘after-market accessories’ category is Segway of Oakland’s Unbreakable Kickstand, made of pure, high-quality aluminum and designed by a former professional welder with Nasa Aimes.

“Ask any Segway owner about the stock kickstand and how often it breaks,” said Segway of Oakland partner, Steve Steinberg. “The stock kickstand cannot support any additional weight, including cargo and handlebar bags, and it cannot handle the weight of a driver standing on the deck. Our rental units have the stock kickstand and people often break them so we have to charge $49 for replacement.

“We have discovered through servicing Segway HTs that the broken kickstand is the No. 1 replacement part,” he added. “We thought we could do better.”

Segway of Oakland’s new Unbreakable Kickstand is guaranteed to withstand the toughest punishment and heaviest payloads. It utilizes a push-button system of shafts, similar to a medical-grade aluminum crutch, and it will not bend or break, even with hundreds of pounds of added weight.

“The Unbreakable Kickstand is much better suited to the rigors of Segway usage than the stock kickstand,” said Segway of Oakland partner, Darren Romar. “It can handle the weight of a rider and also support the Segway in balance mode without moving forward.”

The Unbreakable Kickstand features three positions: Level, to support a carrying system on the front of the machine such as a toolbox or tray; Raised, so no one can step on the platform accidentally; and an additional position for the Segway p-Series so it will function with that smaller model.

“This item already comes standard on the Heavy Hauler and EMT customized models so they can handle the extra weight,” Steinberg said.

The Unbreakable Kickstand retails for $98 only through Segway of Oakland and includes all mounting hardware and accessories needed for easy, at-home installation. The item is shipped in one to two business days via DHL. Contact the company (www.segwayofoakland.com; (800) 659-8731) for more information or to order.

Posted by Industrial-Manufacturing at 07:06 AM | Comments (0)

June 14, 2021

Warnings Regarding Safety of Imported Drugs Force Americans to Buy in Homeland Where Drug Supply Safety Is At Its Weakest, Says DoctorSolve

Biggest argument against importation is safety, but handling processes in the U.S. pose even greater threat to drug safety.

Vancouver, B.C. (PRWEB) June 17, 2021 -- A recent ad campaign sponsored by Big Pharma claims that if Americans are allowed to import their medications from Canada, those drugs may be counterfeit, unregulated and unsafe.

Dr. Paul Zickler, co-founder of DoctorSolve Canadian Pharmacy (http://www.doctorsolve.com) dismisses the campaign as the latest attempt to dupe consumers into buying medications from American suppliers who charge 40 – 70 per cent more. “The safety concern is merely a fear tactic,” Zickler says. “Imported drugs come from the same manufacturers who already provide drugs to U.S. suppliers. In fact, 40 per cent of the prescription drugs Americans consume come from overseas.”

Even Dr. Peter Rost, Vice President with Pfizer, shoots down Big Pharma’s fear mongering. “They take out big ads in American newspapers, and tell us that reimportation is not safe, while they know full well that it’s been done safely and cost-effectively in Europe for over twenty years.”

In fact, Rost believes that drugs coming from other countries may actually be safer than those made in the U.S. “A problem in this country is that our drugs are shipped in big vats to wholesalers, and then poured into smaller, bulk-size containers, from which tablets are dispensed manually to the patient.” This means there are lots of entry points for bioterrorism. “In Europe, drugs are sold in tamper-proof individual bottles or blisters, and no one touches a drug after it leaves the manufacturer.”

Contrary to what the ad campaign is saying, Rost believes that “reimportation is about a safe drug supply, and getting drugs to consumers who can’t afford them.” He maintains that “the fight against reimportation is a fight to continue to charge our uninsured, our elderly, our poor, our weakest, full price, while giving everyone else a rebate.” This, he says is “fundamentally unethical.”

DoctorSolve, a Canadian Internet-based pharmacy intermediary (license #BC Q37), offers lower-cost, long-term prescriptions. A professionally registered pharmacist fills all prescriptions. A certified member of the Canadian International Pharmacy Association, DoctorSolve is ranked as one of the best (five-star) online pharmacies by PharmacyChecker.com. DoctorSolve has filled more than 200,000 U.S. prescriptions.

For more information, call 1-866-732-0305 or visit http://www.doctorsolve.com

Posted by Industrial-Manufacturing at 01:07 AM | Comments (0)

Dr. Tara Levy, Prominent Naturopathic Doctor, Joins Theramedix Advisory Board

Good news announced in the nutraceutical industry: Well-known naturopathic doctor joins the Theramedix advisory board. Dr. Tara Levy has a high regard for nutrition enzyme therapy and believes in using a line of enzymes that is of the highest quality for her patients.

San Francisco, CA (PRWEB) June 13, 2021 -- Theramedix, a niche nutraceutical company that provides health care practitioners with plant-based enzymes, announced today that Tara Levy, N.D. is joining their advisory board. Levy is a Doctor of Naturopathic Medicine who has a clinical practice in the San Francisco Bay Area. She is also the current President of the California Naturopathic Doctors Association and a prominent guest lecturer and writer/advocate in the health and wellness community. She graduated from Bastyr University in 1998 and her undergraduate degree is from Vassar College.


“As a naturopathic doctor, it is important to me to create successful wellness programs for my patients. It is of equal importance to work with suppliers who formulate products that are well researched and are of the highest quality, not only in print, but in practice,” said Dr. Levy. “I have chosen to work closely with Theramedix because their line of plant-based enzymes address the health care needs that I feel are important - potency, purity and integrity.”

“We are honored to have Dr. Tara Levy join our advisory board,” said Kalyna Hanover, Director of Theramedix. “She is a very well respected naturopathic physician who worked with other advocates successfully for Naturopathic Licensure in California. She also has a regard for nutrition enzyme therapy and agrees that proper formulations have been missing from the professional health care market.”

Theramedix is a subsidiary of Enzymedica, a company that has provided high quality enzymes to the retail market since 1998 and is marked by SPINS research as the top retail line nationwide. The Theramedix line is proven to be the highest potency brand and is not available over the counter. It is expected that practitioners will engage as full partners in the promotion and use of these products due to the integrity of the product-line and the exclusive Thera-blend™ system for the top four categories of enzymes: protease, lipase, amylase and cellulase. Thera-blend technology, correctly utilizes each of these categories by representing multiple enzymes in each formula, guaranteeing highest activity in the market.

Theramedix offices are located in San Francisco, California and the distribution facility is in Venice, Florida. Log onto www.theramedix.net for more information.

Media contact:
Constance St. John, The St. John Group
415-454-2243.

Posted by Industrial-Manufacturing at 01:05 AM | Comments (0)

MedicTag, LLC, Announces Expansion Into the Latin Market

MedicTag translates its product to Spanish for entry into the often overlooked Latin market as a first step toward global distribution.

(PRWEB) June 14, 2021 -- MedicTag translates its product to Spanish for entry into the often overlooked Latin market as a first step toward global distribution.

MedicTag, LLC in Deposit, NY is producing and distributing a patent pending USB (Universal Serial Bus) device that stores personal emergency information. The innovative device has the capacity to store and display critical information used by emergency personnel and can be carried on a key ring.

MedicTag was originally unveiled last October at the National EMS Expo in Atlanta, Georgia to an overwhelmingly positive response from EMS professionals and displayed again this March at the EMS Today conference in Philadelphia, Pennsylvania where it was once again very well received.

The company began selling the device, simply called MedicTag, last fall and has been pleased to experience steadily increasing sales from the very beginning. The product uses a USB flash drive to store emergency information such as identification, existing medical conditions, medications, doctors, surgeries and emergency contacts. MedicTag uses a simple software menu that makes it very user friendly and the device will work with most USB equipped computers.

MedicTag has recently acquired new distributors in the US, Canada, Australia and the UK and plans to expand distribution providing what may be a life saving service to people worldwide.

As a first step in achieving that goal the company is in the process of tranlating the device to Spanish for distribution in latin countries and is actively seeking distribution channels in Mexico and other central and South American countries. Interested parties may view distributor information in both English and Spanish at the company website.

MedicTag, LLC is a privately held company located in Deposit , New York. For more information regarding MedicTag LLC, visit the company's site at http://www.medictag.com or http://medictag.com/es.

Contact:
Edward Ricci
607-467-2767
e-mail protected from spam bots

Posted by Industrial-Manufacturing at 01:04 AM | Comments (0)

New Minco 384-Hole Heater Responds to Industry Move to 384-Hole Microplate - New Proprietary Non-Mechanical Routing Technology Tackles Uniform Heating Challenge

Minco today announced the release of a breakthrough 384-hole heater, which provides critical temperature uniformity across a 384 well Polymerase Chain Reaction (PCR) sample block.

New York, NY (PRWEB) June 13, 2021 -- MD&M; East - Minco, (www.minco.com/384) a designer and manufacturer of critical components for critical medical applications, today announced the release of a breakthrough 384-hole heater, which provides critical temperature uniformity across a 384 well Polymerase Chain Reaction (PCR) sample block.

“As thermal cycling machinery in the IVD market rapidly moves from a 96-hole to a 384-hole microplate, steal rule dies are becoming less effective for the development of smaller heating components,” said Brian Williams, Minco Marketing Manager. “Minco engineers recognized that alternate routing techniques, used to develop components in our flex division, could produce the substantially smaller heating components required to effectively work within the tight dimensions of the 384-hole microplate.”

This proprietary Minco technology enables extremely tight hole-to-hole tolerance allowing for near perfect registration of the Minco 384-hole heater to a PCR sample block. The seamless fit of the heater provides superior heat transfer critical to fast temperature cycling environments. It also enables an unobstructed view of the reaction process because, what can be large, heating components are eliminated.

The Minco 384-hole heater contains an etched Thermofoil™ element which also encourages heat uniformity as reagents are cycled through high-throughput PCR thermal well steps of denaturing, annealing and extension.

“Minco recognizes that the IVD market is continually reducing size, adding features and increasing the sophistication of temperature cycling machinery,” added Williams. “Minco engineers are committed to developing heaters that produce higher throughput, optimal uniformity and tighter dimensional tolerance.”

The Minco 384-hole heater can be constructed with a broad array of insulation materials depending upon its client’s emissivity needs.

The 384-hole heater is available with an integrated thermistor, or RTD, and can be custom profiled to match any system. For more information about the 384-hole heater please contact Brian Williams, Marketing Manager, at 763-586-2903, or visit www.minco.com/384.

Minco designs, manufactures and markets critical components for critical applications. The company is unsurpassed in its ability to integrate and assemble Thermofoil™ Heaters, Flex Circuits, Sensors and Instruments into a single component for greater efficiency. Minco helps companies minimize the risk of product failure by providing highly reliable components and expert design services.

Posted by Industrial-Manufacturing at 01:02 AM | Comments (0)

Minco Releases New Pipette Heating System for Immunoassay Applications - Thinnest Etched-foil Heater on the Market Eliminates Need for Supporting Heat Sources

Minco today announced the release of the thinnest immunoassay pipette heating system available.

New York, NY (PRWEB) June 13, 2021 -- MD&M; East - Minco, (www.minco.com/pipette) a designer and manufacturer of critical components for critical medical diagnostic applications today announced the release of the thinnest immunoassay pipette heating system available.

“Prior to the development of the Minco Pipette heating system, medical diagnostic professionals experienced difficulty in maneuvering immunoassay applications,” said Brian Williams, Minco Marketing Manager. “In order to facilitate accurate immunoassay readings, Minco engineers developed a pipette heater designed to function without additional bulk such as tubular heaters, fans and other supporting framework.”

At a mere .003” (.076 mm) thick, the Minco Pipette heating system is the thinnest, lightest and most flexible pipette heater on the market today. The heater also features an extremely fast warm-up time from room temperature to body temperature in under a second.

The new Minco pipette heater boasts the use of Thermofoil™, a Minco-developed etched-foil heating technology, which when combined with polyimide insulation, wraps completely around a .060” (1.52 mm) pipette.

When a Pipette is completely wrapped by the new Minco Pipette heater, the temperature of the blood or biological chemistry can be kept at a uniform and accurate heat level. This means that the time necessary to adjust temperature is reduced and money is ultimately saved.

“The new Minco pipette heater is a tangible demonstration of Minco’s dedication to providing the medical diagnostic community with complete thermal, sensing and packaging solutions designed to shorten medical diagnostic supply chains and increase time-to-market,” said Williams.

For more information regarding Minco’s pipette heaters, please contact Brian Williams, Minco Marketing Manager, at 763-586-2903, or visit www.minco.com/pipette.

Minco designs, manufactures and markets critical components for critical applications. The company is unsurpassed in its ability to integrate and assemble Thermofoil™ Heaters, Flex Circuits, Sensors and Instruments into a single component for greater efficiency. Minco helps companies minimize the risk of product failure by providing highly reliable components and expert design services.

Posted by Industrial-Manufacturing at 01:00 AM | Comments (0)

Minco Launches Let’s Talk E2E Online Engineer Community - Serves Flex Circuit, Heater, Temperature and Sensor Interests

Minco today announced the launch of its “Let’s Talk E2E - Engineer to Engineer” online community is for engineers with interests in flex circuit, heater, temperature and sensor solutions.

New York, NY (PRWEB) June 13, 2021 -- MD&M; East - Minco, (www.minco.com/E2Eoverview.com) a designer and manufacturer of critical components for critical medical applications, today announced the launch of its “Let’s Talk E2E - Engineer to Engineer” online community is for engineers with interests in flex circuit, heater, temperature and sensor solutions.

“More than ever before, design engineers are being asked to provide input and direction in areas outside of their direct academic experience,” said Mary Rapaport, Minco Marketing Director. “By providing a resource for quick and reliable information, Minco believes it will contribute to the success of not only its customers, but also to the engineering community at large.”

Key among the features of “Let’s Talk E2E” is the E2E online discussion forum, an educational networking tool for engineers who seek, or wish to share, useful and meaningful information. The Forum breaks down geographical barriers and allows engineers from around the world the opportunity to exchange insight and knowledge.

Actual questions posed by engineers using the E2E Forum include:
“I am looking for a material suggestion for a medical application. I am looking to find a thermally conductive material that will stand up to thousands of cycles of sliding contact with a disposable plastic part. It is to be applied to a Polyimide surface. Temperature is around 80°C. Any Suggestions? I thought about maybe a foil? Is there anything relating to the fact that this is in a medical device that I should be concerned about in the selection of this?”

“I am currently prototyping a heater design with catalog Polyimide heaters. I would like to know how I can minimize the capacitive coupling current that I am seeing occur?”

Other features in the “Lets Talk E2E” community include:
- Ask the Experts – an opportunity for design engineers with specific questions regarding flex circuits, heaters, instruments or sensors to get answers from a Minco engineer with expertise in that particular area
- White Papers such as:
o “Comparison of Thin-Film and Wire-Wound Heaters for Transparent Applications”
o “Prototyping Techniques for Etched-Foil Heaters”
o “Sensing Fluid Temperature with Thermal Ribbons”
-Engineering Tools – which include calculators, drawings and configurators

For more information about the Minco “Let’s Talk E2E” community, please contact Mary Rapaport, Marketing Director, at 763-586-2910, or visit www.minco.com/E2Eoverview.

Minco designs, manufactures and markets critical components for critical applications. The company is unsurpassed in its ability to integrate and assemble Thermofoil™ Heaters, Flex Circuits, Sensors and Instruments into a single component for greater efficiency. Minco helps companies minimize the risk of product failure by providing highly reliable components and expert design services.

Posted by Industrial-Manufacturing at 12:58 AM | Comments (0)

June 10, 2021

New Home Medical Device Great for Footwear

The Shoe & Boot Valet is a new, patented home medical device that greatly simplifies putting on and taking off footwear.

(PRWEB) May 5, 2022 -- An Oklahoma company has developed a revolutionary new home medical device – the Shoe & Boot Valet – that greatly simplifies putting on and taking off footwear for millions of people with physical disabilities, back pain, pregnancy and other limitations.

Tulsa-based Rocky Mountain Marketing has developed its Shoe & Boot Valet to enable users to perform this daily task without bending their neck, back, hips or knees. Made of a lightweight aluminum alloy and durable nylon, this home medical device can be used with almost any type of footwear – whether the user is standing, sitting or lying down. The Shoe & Boot Valet weighs only one pound and is especially helpful for those suffering from conditions that affect hand strength, since the Valet requires very little grip strength.

“We’ve worked several years on this unique home medical device and are excited we can now make it available to our customers,” said Trent Morris, Rocky Mountain Marketing’s director of sales and marketing. “The Shoe & Boot Valet is the perfect gift for a friend or loved one in need, and its innovative design has the potential to greatly improve the lives of millions worldwide.”

In addition to the Shoe & Boot Valet, Rocky Mountain Marketing recently patented a new “bootjack” device that attaches to the Valet, giving users twice the leverage and strength when removing difficult shoes and boots.

The Shoe & Boot Valet retails for $49.95 and is now available for purchase online at www.shoebootvalet.com or by calling 1-888-593-6353.

More information is available for dealers and distributors online at www.shoebootvalet.com.

Contact:
Mike Lyon
Rocky Mountain Marketing, LLC.
1-888-593-6353
www.shoebootvalet.com

Posted by Industrial-Manufacturing at 10:14 PM | Comments (0)

June 09, 2021

Environmental Concerns Prompt Ink Manufacturer to Install DCF Filter

Progressive Ink manufactures printing inks for flexible packaging, such as snack packaging, milk cartons and bread bags. In the St. Louis, Missouri manufacturing facility, pressurized bag filters used in the fill area were generating a lot of waste. During a batch run, up to twenty filter bags were replaced and thrown away. Progressive Ink was concerned about the large amounts of waste generated and its effect on the environment. There were other problems too. Occasionally, a bag would rupture and contaminate the ink being processed for shipping. Progressive Ink also experienced variations in the filtering performance of the bags.

(PRWEB) June 9, 2021 -- Situation:
Progressive Ink manufactures printing inks for flexible packaging, such as snack packaging, milk cartons and bread bags. In the St. Louis, Missouri manufacturing facility, pressurized bag filters used in the fill area were generating a lot of waste. During a batch run, up to twenty filter bags were replaced and thrown away. Progressive Ink was concerned about the large amounts of waste generated and its effect on the environment. There were other problems too. Occasionally, a bag would rupture and contaminate the ink being processed for shipping. Progressive Ink also experienced variations in the filtering performance of the bags.

Our Solution:
With few solutions available on the market, Progressive Ink had trouble finding a filter that could filter tight enough to meet the industry requirements of at least 75 micron retention. Their extensive search ended with the Ronningen-Petter Mechanically-Cleaned DCF filter — which offered filtration capabilities well beyond the industry standard. The company installed a DCF-800 filter that filters to 50 micron. It is equipped with pneumatic timers, Teflon®‚ seals, a pneumatic actuator used to move the disc and clean the screen and a purge valve actuator that, when activated, rids the housing of collected debris. Operation of the DCF is easy, and it features a stainless steel pressure-rated housing. The DCF’s filtering screen is specially machined so material will not get wedged into the media surface.

Results:
The DCF filter’s specially machined filtering screen offers concise and consistent particle retention, so Progressive Ink no longer suffers from variations in filtering performance. And, Progressive Ink is able to reprocess its collected waste. Waste collected by the Ronningen-Petter DCF filter is highly concentrated, so that overall purge volume is extremely small. The small amounts of waste collected in the DCF purge chamber are transferred back to the premix tank. Reprocessing rather than disposing of collected waste saves disposal costs and reduces product loss. Progressive Ink is also very pleased with the consistently low differential pressure the DCF filter maintains, and the even throughput levels it provides to the fill line.

Conclusion:
The Ronningen-Petter DCF filter provides environmentally sound filtration while improving the ink’s overall quality. Frank Davis, maintenance superintendent at Progressive Ink said, “We plan to replace all of our bags with DCF filters.”

Teflon® is a registered trademark of E.I. DuPont de Nemours and Company

For more information visit www.RPAprocess.com, e-mail at e-mail protected from spam bots or call us at +1 269 323 1313.

Posted by Industrial-Manufacturing at 03:52 AM | Comments (0)

June 08, 2021

Kathy Johnson Joins Simply Retail

For the last seven years, Simply Retail has been the nation's leader in healthcare retailing. They are pleased to announce a new member of their team, Kathy Johnson, as manager of retail implementation. Simply Retail has helped numerous hospitals and clinics boost their revenues and expand patient care through industry-proven retail strategies.

Minneapolis, MN (PRWEB) June 8, 2021 -- Simply Retail, the nation’s leader in healthcare retailing, recently welcomed Kathy Johnson as its manager of retail implementation. Johnson joins Simply Retail’s team of experts with an extensive background in all areas of product retailing.

President and Simply Retail Founder, Mindy Thompson said Johnson will be an asset to her already skilled staff. “She has a lot of knowledge in the areas of store planning and product selection,” said Thompson. “Kathy’s expertise will help our clients increase revenues and enhance customers’ experiences with the healthcare setting.”

Before joining Simply Retail, Johnson worked with Creative Kidstuff, a renowned specialty toy retailer based in Minneapolis. Her skill and experience with Creative Kidstuff led her to Simply Retail and the company’s growing impact in the healthcare community.

“Healthcare retailing is the next big opportunity in both the healthcare and retail segments,” Johnson said. “I love learning all I can to make hospitals aware of this great prospect and helping them enhance their patient and visitor experience.”

Founded in 1994, Simply Retail is a Minneapolis-based retail consultancy firm specializing in healthcare retailing. Simply Retail is the voice and pioneer of healthcare retailing. For the last seven years, Simply Retail has focused its retail expertise solely on healthcare, creating the processes and details necessary to make healthcare retailing a success. Simply Retail has helped numerous hospitals and clinics boost revenues and expand patient care through industry-proven retail strategies. For more information about Simply Retail, please call 612.659.8200 or visit www.simplyretailinc.com.

Contact:
Simply Retail Inc.
612.659.8200
www.simplyretailinc.com

Posted by Industrial-Manufacturing at 03:17 AM | Comments (0)

Aloe Vera, Natural Alternative Medication Dermatologists Should Consider

As more patients who suffer from skin ailments seek cost-effective alternative medications, Dermatologists would be well advised to research the time-tested results of the Aloe Vera plant’s gel.

(PRWEB) June 8, 2021 -- As more patients who suffer from skin ailments seek cost-effective alternative medications, Dermatologists would be well advised to research the time-tested results of the Aloe Vera plant’s gel. Why more physicians do not recommend the use of Aloe Vera to their patients is somewhat of a mystery. Could it be that the amazing results reported by users of Aloe Vera causes doctors to question the validity of the plant’s ability to heal? “I understand why,” commented Comer. “It is truly difficult to conceive of a single plant with as many healing attributes as those of the Aloe Vera. By nature we have a tendency to distant ourselves from things we do not fully understand,” he added. However, when doctors fail to explore the benefits of alternative medications, the patient is the loser. Generally, it is a patient dissatisfied with the results of a physician’s prescribed medication that will ultimately seek and try other cures. Patients that experience positive results from their use of Aloe Vera are often the leading cause for a physician’s consideration to use this natural cure in his or her practice and recommend it to other patients.

Mother Nature has a remarkable way of pulling together the right combination of nutrients that work cooperatively to produce a powerful and effective skin and digestive tract remedy. Often referred to as the Medicine or Burn plant, and prized for its medicinal benefits, the use of Aloe Vera has been documented for thousands of years. Scientists, researchers and medical professionals have tried for many years, without success, to isolate the key elements that produce the dramatic results obtained from the plant’s gel. It is now the general consensus that no one element that make up the chemistry of the plant is able, in itself, to result in the natural healing and detoxifying powers it produces. Instead, the synergy of the more than 75 nutrients it contains contributes in varying degrees to the results.

In addition to the traditional uses of Aloe Vera for burns, minor cuts and infections, individuals who suffer with skin conditions such as eczema, psoriasis, ulcers, acne and like conditions of the skin have consistently obtained outstanding results from its use, even when other controlled medications failed. The benefits of Aloe Vera do not end with its external applications. Studies have shown that those who suffer from common digestive tract ailments like irritable bowel syndrome (IBS), dyspepsia, indigestion and heartburn reported significant improvement in their conditions because of daily drinking Aloe Vera gel. Perhaps one of the greatest attributes of Aloe Vera is that it is non-toxic and since it is a nutrient and not a drug, it can safely be taken with other medications; however, consult your physician before doing so.

To summarize, the Aloe Vera plants has the ability to provide essential nutrients; to promote healthy tissue growth by the reduction of inflammation; and to kill bacteria and other foreign organisms that attack damaged or unhealthy skin. It not only works with the skin, but also the digestive tract and the body’s immune system. It is Mother Nature’s solution to living a healthier more energized life.

The author, Arthur Comer is the owner and general manager of ALCJR Enterprises, a 5-year old Midlothian, Virginia-based mail-order company that grows and retails Aloe Vera, Tillandsia and Anthurium plants. His informative articles appear in numerous online and hard copy publications. He is also an independent distributor of Forever Living Products, Inc., a multi-billion dollar international company that manufactures Aloe Vera-based Health and Beauty products. Visit his website for more information about the remarkable medicinal benefits of the Aloe Vera plant. http://www.alcjr.com.

Posted by Industrial-Manufacturing at 03:14 AM | Comments (0)

June 03, 2021

Baxa Sponsors Team In Courage Classic Fundraiser For The Children’s Hospital

Baxa Corporation is sponsoring a bicycle racing team for the 16th annual Courage Classic ride to raise money for The Children’s Hospital of Denver. Baxa will provide financial support for the team, along with jerseys and riders. Team captain Jerrod Milton, Director of Campus Transition and Occupancy for the hospital’s new Fitzsimons facility, will lead 35 riders for Team Road Rage, including Baxa executives and associates.

Englewood, CO (PRWEB) June 3, 2021 -- Baxa Corporation is sponsoring a bicycle racing team for the 16th annual Courage Classic ride to raise money for The Children’s Hospital of Denver. Baxa will provide financial support for the team, along with jerseys and riders. Team captain Jerrod Milton, Director of Campus Transition and Occupancy for the hospital’s new Fitzsimons facility, will lead 35 riders for Team Road Rage, including Baxa executives and associates.

One of Colorado’s premiere cycling events, the Courage Classic is a three-day, 157- to 203-mile adventure in Colorado’s high country from Leadville to Summit County and back. From July 16th to 18th, cyclists of all ages and abilities will experience the challenge of mountain riding while supporting this important cause. The 2005 fundraising goal for Team Road Rage is $25,000.00.

Not all of the Courage Classic fundraising efforts involve strenuous bike riding, however. Team supporters can raise money by participating in a dinner fundraiser June 8th at the Littleton Texas Roadhouse near Kipling and C-470. From 4:00 to 10:00 PM that evening, for every guest who mentions Team Road Rage the restaurant will donate 10% of their total bill towards the team goal.

Baxa Chairman and CEO, Greg Baldwin, rode in the 2004 Courage Classic and joins Team Road Rage again this year. “This is great event to give back to our community while having some fun with colleagues and friends,” he notes. “Baxa is delighted to be both a supporter and a participant in this fundraiser and I encourage all of our associates to ride, pledge or dine in support of The Children’s Hospital.”

About Courage Classic
The 2005 Courage Classic benefits The Children’s Hospital of Denver. Since its inception, thanks to thousands of generous participants and supporters, the Courage Classic has raised more than $13 million. The Children’s Hospital of Denver is one of the nation’s top pediatric hospitals, promoting children’s health through high-quality, coordinated programs of patient care, education, research and advocacy. Funds raised by the Courage Classic go to important community programs such as The Handicapped Sports Program, The Children’s Cancer Center, The Children’s Hospital Heart Institute and the Newborn Center. Fundraising efforts also help build Children’s new facility at Fitzsimons. For more information on the Courage Classic visit http://www.couragetours.com. To pledge support for Team Road Rage, visit http://www.kintera.org/siteapps/teampage/ShowPage.aspx?c=gvKRLaMZIwG&b;=310310&teamid;=859594.

About Baxa Corporation
Celebrating 30 years of business in 2005, Baxa Corporation is a Denver-based manufacturer of medical devices and systems for preparing, handling, packaging, and administering liquid medications. The company manufactures and markets a wide range of healthcare products for use in hospitals, critical care units and alternate-site pharmacies. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada, the United Kingdom; Denmark, and Germany; and distribution partners worldwide. Further information is available at http://www.baxa.com.

Contacts:
Marian Robinson, Vice President, Marketing
Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157
Email: e-mail protected from spam bots

Maggie Chamberlin Holben, APR,
Absolutely Public Relations: 303.984.9801 or 303.669.3558
Email: e-mail protected from spam bots

Posted by Industrial-Manufacturing at 03:14 AM | Comments (0)

June 02, 2021

Los Gatos Family Holds Fundraiser To Purchase Lifesaving CPR Devices for Local Fire Departments

The Counting Blessings Group, an affiliate of the Los Gatos Community Foundation and founded by the Weich family, will hold a fundraiser June 5th from 4-7p.m. to raise funds to purchase Autopulse™ Resuscitation System devices for the Los Gatos and Saratoga fire departments. On March 20, 2004, fifty-seven year old Caralee Weich suffered a sudden cardiac arrest and lay without a pulse for almost thirty minutes. Doctors, firemen, paramedics and medical professionals all credit the Autopulse, a new CPR machine, with saving her life that afternoon and agree that her 100 percent recovery is a true miracle.

Los Gatos, CA (PRWEB) June 2, 2021 -- The Counting Blessings Group, an affiliate of the Los Gatos Community Foundation and founded by the Weich family, will hold a fundraiser June 5th from 4-7p.m. to raise funds to purchase Autopulse™ Resuscitation System devices for the Los Gatos and Saratoga fire departments. On March 20, 2004, fifty-seven year old Caralee Weich had enjoyed an afternoon performance of MAMMA MIA! in San Francisco when she suffered a sudden cardiac arrest and lay without a pulse for almost thirty minutes. Doctors, firemen, paramedics and medical professionals all credit the Autopulse, a new CPR machine, with saving her life that afternoon and agree that her 100 percent recovery is a true miracle.

“I am incredibly fortunate to have been treated by the paramedics with one of the few AutoPulse machines in the Bay Area and I am tremendously blessed to have my life back again,” marveled Caralee Weich. “Our family’s campaign to bring our community together to raise awareness about cardiac arrest and give back to them somehow is so rewarding for us. This experience has certainly given me a newfound appreciation of how precious life is and I feel it’s now my responsibility to educate others about my story and this truly miraculous new medical device,” she continued.

Developed by Revivant Corporation, recently acquired by ZOLL Medical Corporation (www.zoll.com), the Autopulse is a comprehensive resuscitation platform that has the power to transform the way CPR is performed by medical professionals. The small, portable device pumps the patient's chest to circulate blood to the heart, brain and other vital organs during cardiac arrest treatment and allows medics to focus on complementary interventions such as drugs, ventilation and defibrillation, greatly enhancing the resuscitation process for rescuers in and out of the hospital.

“I believe the Autopulse provided enough circulation to the brain and heart to maintain biologic functions during the thirty minutes Caralee was being resuscitated,” said Dr. Arthur Chin, cardiologist at St. Francis Hospital in San Francisco. “Caralee has completely recovered neurologically and I’m very grateful for the Autopulse for playing such a major role in that.”

Cardiac arrest statistics:
- Sudden cardiac arrest claims the lives of over 450,000 people every year. That's one life lost every two minutes.
- In a city the size of Los Gatos, more than 25 people die every year from cardiac arrest.
- Survival rate is less than 5% and has not improved in 30 years.
- Twice the number of women die each year from cardiac arrest and heart related diseases than from all types of cancers combined.

The garden reception at La Estancia, owned by David Stonesifer and Larry Arzie, will feature live and silent auctions and musical performances by local artists, Kaweh, Gillian Harwin and Francois & Rodrigo. Special guest speakers include Caralee Weich, Sebastian Wong, the paramedic captain from the San Francisco Fire Department who came to Caralee’s immediate aid, and Steve Staump, deputy chief at the Santa Clara Fire Department.

Tickets to the event are $100 (tax deductible) and can be purchased through Shannon Weich at 408-219-9636, www.countingblessings.com or at the door the day of the event. For additional information please refer to the web site.

Autopulse is a registered trademark of Zoll Medical Corporation. and/or its affiliates in the U.S. and certain other countries.

Press contact:
Shannon Weich
Counting Blessings Group
408.219.9636
e-mail protected from spam bots

Posted by Industrial-Manufacturing at 03:11 AM | Comments (0)